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ABSTRACT 
Purpose: Ankle foot orthoses (AFOs) are frequently prescribed to address gait impairments for 
children with cerebral palsy (CP). Successful treatment with AFOs depends on optimal 
prescription, matching the design of the brace to the individual child’s physical impairments; 
however, research evidence does not exist to help health care professionals decide on the best 
AFO design to meet each child’s needs. Therefore, this thesis explored current AFO prescription 
practices, and aimed to improve evidence to assist clinicians in making prescription decisions for 
children with CP.  
 
Methods and Results: To examine the experiences and perspectives of clinicians on AFO 
prescription for children with CP, we conducted focus groups and semi-structured interviews 
with 32 clinicians who were involved with AFO prescription for children with CP in five 
Canadian rehabilitation facilities. Using Interpretive Description as a framework for analysis, we 
identified three categories from the data: 1) What is made, 2) How it is used, and 3) Factors that 
support or challenge outcomes. Throughout the interviews, the theme of prescription as a 
collaborative, iterative, and individualized process emerged. 
 
To explore evaluation and clinical decision-making practices of physical therapists for AFO 
prescription and follow-up, we invited Canadian physical therapists (PTs) working with children 
who have CP to complete an online survey. Sixty completed responses were received. Three 
researchers conducted a conventional content analysis to examine the open-ended responses, and 
descriptive statistics were used to summarize the closed-ended responses. Three themes were 
identified: 1) Focus on impairment level measures, 2) Inconsistent practices between PTs, and 3) 
Lack of confidence/knowledge about casting positions and AFO types.  
 
To investigate the effects of individualizing the angle of the ankle in the AFO on walking 
mechanics and function, gait biomechanics were studied in ten children with CP. Fifteen 
typically-developing children provided normative data. Using three-dimensional gait analysis, 
kinematics and kinetics were compared between the child’s usual AFO(s) and AFOs that were 
fabricated with an ankle angle that was individualized for each child. Net responses to the 
individualized ankle angle were positive for 60% of limbs, negative for 40%. The greatest 
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benefits were observed at the knee, suggesting that this may be a beneficial approach to orthotic 
intervention for some children with CP. 
 
Conclusions: There is limited understanding of how AFOs are prescribed for children with CP 
in Canada. This thesis highlights the importance of multidisciplinary collaboration, objective 
evaluation, and individualized clinical problem-solving to facilitate the evolution of the AFO 
prescription from a medical directive to an orthotic device that optimally benefits the child. This 
is the first step toward the development of guidelines to help clinicians improve AFO 
prescription for children with CP.  
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GLOSSARY 
Ankle-foot orthosis: an orthosis that spans the ankle and foot segments of the body 
Equinus gait: One of the most common gait patterns associated with CP (the most common 
according to Cornell, 1995); an inefficient toe-walking pattern associated with ankle 
plantarflexor muscle tightness and spasticity. 
Gait quality: The extent to which the gait pattern deviates from normal (Lord, Halligan, & 
Wade, 1998). 
Gross Motor Function Classification System (GMFCS): An internationally-recognized 
system for classifying children based on their functional motor abilities (Palisano et al., 
2007). 
International Classification of Functioning, Disability and Health (ICF): An internationally-
recognized framework for measuring health and disability, classifying health and health-
related domains, and that provides a common language for this discussion (World Health 
Organization, 2016a). 
Orthosis: An “externally applied device used to modify the structural & functional 
characteristics of the neuromuscular & skeletal system” (ISO, 1989). 
Shank to vertical angle (SVA): The angle between the anterior tibia and vertical in the sagittal 
plane. 
Temporal Midstance (TMSt): The temporal midpoint of the stance phase (i.e., 30% of the gait 
cycle or 50% of the time interval from initial contact to toe off) (Gibson, et al., 2006). 
Trim-lines (of an AFO):  Refers to the way the plastic of the orthosis is trimmed during 
fabrication. For example, trim lines may alter the stiffness of the brace and the motion it 
allows. By locating the edge of the AFO (i.e., the trim lines) anterior to the malleoli, less 
sagittal plane ankle motion will be allowed and the ankle and knee will be more stable; more 
dorsiflexion and plantarflexion will be allowed if the trimlines are posterior to the malleoli 
(Supan, 2008). Locating the trimlines distal to the metatarsophalangeal joints will prevent 
extension while locating them proximally will allow more extension. 
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CHAPTER 1: INTRODUCTION, PURPOSE, AND OBJECTIVES 
Rehabilitation for children with neurological conditions such as cerebral palsy (CP) 
frequently focuses on optimizing gait quality in order to improve gait efficiency and appearance 
and to reduce musculoskeletal strain. It is common practice for ankle-foot orthoses (AFOs) to be 
prescribed to address these aims. AFOs can influence joint motion and loading patterns by 
compensating for motor impairments -- such as poor motor control, and plantarflexor muscle 
spasticity, inflexibility, and weakness – that are prevalent in this population.  
The success of AFO intervention relies on individualized prescription of the AFO design, 
delivering an orthosis that is well matched to the child’s specific motor impairments (Davids, 
Rowan, & Davis, 2007; Harlaar et al., 2010). However, conventional AFO recommendations 
tend to be generalized, based on simplified biomechanical descriptions of various brace 
categories (e.g., hinged AFOs, solid AFOs) (Davids et al., 2007; Novacheck, 2008), and broad 
CP subtypes (e.g., unilateral CP/hemiplegia, bilateral CP/diplegia or quadriplegia) and gait 
pattern (e.g., equinus, crouch gait) (Rodda & Graham, 2001; Rodda, Graham, Carson, Galea, & 
Wolfe, 2004; Sutherland & Davids, 1993). AFO prescription is often based on trial and error, 
and lacks specificity, as there is little evidence to guide the selection of the most suitable AFO 
design for each individual child (Morris, Bowers, Ross, Stevens, & Phillips, 2011). 
While AFOs have demonstrated the potential to improve various aspects of walking 
(Figueiredo, Ferreira, Maia Moreira, Kirkwood, & Fetters, 2008; Morris et al., 2011), few studies 
present results that can be applied to improve our understanding of how to effectively 
individualize the orthotic type and design for each child (Bowers & Ross, 2009). Recently, it has 
been suggested that clinical prescription practices may not optimize the intervention’s potential 
(Ries, Novacheck, & Schwartz, 2014, 2015), and that they may not be based on biomechanical 
rationale (National Health Service Quality Improvement Scotland, 2009). The literature’s lack of 
attention to the individualization of AFO prescriptions may contribute to mixed results in some 
studies, and the current paucity of evidence-based clinical prescription guidelines. 
An aspect of the AFO prescription that may be individualized is the angle of the ankle in 
an AFO (AA-AFO). The AA-AFO is conventionally set at 90˚, and there is a lack of clinical 
guidance for considering the severity of plantarflexor muscle tightness or the force required to 
sustain that angle. For example, “severe equinus” is listed as a contraindication for a solid AFO 
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in one text (Beaman, Kalisperis, & Miller-Skomorucha, 2014), while another (Novachek et al., 
2009) lists “severe spasticity” as an indication for solid AFOs. Neither define “severe” and 
neither discuss the AA-AFO as a consideration in the prescription. However, it has been 
suggested that a better match between the child and the orthosis may be achieved by 
individualizing the AA-AFO based on a physical assessment of the child’s foot and ankle that 
considers the measured length of the gastrocnemius muscle as a starting point (Owen, 2005, 
2010). While it is likely that the AA-AFO influences the resultant gait pattern and ultimate 
success of the orthotic intervention (Eddison & Chockalingam, 2013; Jagadamma et al., 2015; 
Owen, 2014), clinicians lack research to support evidence-based prescription decisions regarding 
the AA-AFO. 
The overarching aim of this thesis was to improve the evidence available to clinicians to 
guide AFO prescription for children with CP and contribute to the development of best practice 
guidelines for AFO prescription for this population. In order to identify a suitable focus for 
improving care, it was necessary to first examine current practice and identify strengths and 
challenges within this landscape. This thesis is comprised of three studies (Chapters 3-5). The 
objectives for each study and the hypotheses for study 3 are described below. 
 1.1 Clinician Experiences with Prescription of AFOs for Children with CP 
The objective of this qualitative study was to explore clinician perspectives about the 
factors that influence AFO prescription for children with CP in Canada. A secondary aim was to 
compare the results with the current literature and provide recommendations for clinical practice. 
1.2 Physical Therapists’ Use of Evaluation Measures to Inform AFO Prescription for 
Children with CP 
In study 1, physical assessment emerged as an area that may be improved to benefit 
outcomes. Therefore, the purpose of this study was to gain an understanding of physical 
therapists’ (PTs’) evaluation practises for AFO prescription at both initial prescription and 
follow-up. Specifically, we hoped to improve our understanding of what is evaluated, how it is 
evaluated, and how evaluation informs prescription. As well, we aimed to provide 
recommendations to improve current practice by comparing our results with the published 
literature. 
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 1.3: The effect of the AA-AFO on walking in children with CP 
About half of children with CP use AFOs to improve their walking ability (Wingstrand, 
Hägglund, & Rodby-Bousquet, 2014). More evidence is needed to guide individualized AFO 
prescription decisions, based on biomechanical principles. The objective of this study was to 
compare conventional, community-prescribed AFOs with AFOs that were fabricated with 
individualized AA-AFOs based on clinical measures of the child’s plantarflexor muscle state (as 
described by Owen, 2005, 2010). This comparison had two primary investigative aims: 
1.3.1 Aim #1: gait mechanics 
 To investigate gait kinematics and kinetics during walking in children with CP and 
spastic equinus, comparing their usual AFOs with individualized AA-AFOs. The hypothesis was 
that, compared to their usual AFOs, the children with CP would have gait mechanics closer to 
typically developing children when the AA-AFOs were individualized to accommodate calf 
muscle tightness and stiffness. 
1.3.2 Aim #2: functional mobility 
To examine the effects of a child-specific, individualized AA-AFO on functional 
mobility. The hypothesis was that an individualized AA-AFO would not impair mobility 
compared to the child’s usual AFO, and that children would perform similarly in tests of 
functional mobility wearing each orthosis. 
 
Little is known about current AFO prescription practices; yet the success of this 
intervention rests on their efficacy. An understanding of current practices, treatment 
philosophies, and contributing factors is necessary to identify stakeholder needs, barriers, and 
gaps in evidence-based care, and will help to direct the focus of future research and clinical 
recommendations. This is the multi-faceted context in which evidence-based recommendations 
will be implemented. By improving the evidence on which prescription decisions are based, 
service provision and orthotic outcomes are likely to improve for this group of children.  
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1 Gait Impairments in CP 
CP is a group of disorders of movement and postural control that is caused by a 
disturbance to the developing fetal or infant brain before, during or after birth (Rosenbaum et al., 
2007). This condition is the most common cause of childhood disability in western countries, 
affecting 2-3 of every 1000 live births (Oskoui, Coutinho, Dykeman, Jetté, & Pringsheim, 2013; 
Smith, Kelly, Prkachin, & Voaklander, 2008). It is associated with a wide range of possible 
motor and cognitive impairments, activity limitations, and clinical presentations.  
Because of this heterogeneity, categorization and classification are necessary mechanisms 
for describing and comparing the nature and severity of the condition, predicting an individual’s 
needs and outcomes, and evaluating change over time (Rosenbaum et al., 2007).  Rosenbaum 
and colleagues (2007) recommend classifying children with CP according to four main 
components: 1) motor abnormalities, including the nature and typology of the motor disorder 
(e.g., tonal and movement abnormalities such as hypertonia, hypotonia, spasticity, athetosis, 
ataxia, or dystonia) and functional motor abilities (e.g., using the Gross Motor Function 
Classification System (GMFCS); Palisano et al., 2007); 2) accompanying impairments (e.g., 
secondary musculoskeletal problems and/or non-motor difficulties like seizures or sensory 
impairments); 3) causation and timing when there is a clearly identified cause, such in post-natal 
CP (e.g., meningitis); and 4) anatomical distribution and neuro-imaging findings, if present. 
Traditionally, terms such as hemiplegia, diplegia, and quadriplegia have been used to describe 
anatomical distribution; however, these terms are imprecise and not reliably used; therefore, a 
more reliable approach is to use the term unilateral CP when one side of the body is impaired 
(instead of monoplegia and hemiplegia), and bilateral CP when both sides are involved (instead 
of diplegia and quadriplegia) (Palisano, Rosenbaum, Bartlett, & Livingston, 2008; Rosenbaum et 
al., 2007).  
A systematic review by Dobson and colleagues (2007) summarized the range of 
classification systems to describe the gait patterns observed in this population; however, none of 
these classification systems adequately describes the range of gait patterns that exist. These 
systems either lack adequate psychometric properties or were developed using arbitrary 
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definitions/categories. Few described the relationship between clinical impairments and the 
categories. 
More than 65% of children with CP are able to walk to some extent, using a wide range 
of gait patterns and strategies (Kirby et al., 2011; Pharoah, Cooke, Johnson, King, & Mutch, 
1998). For ambulatory children with CP, the neurological injury may result in primary physical 
impairments such as abnormal muscle activation, force production, and motor control (Gage & 
Schwartz, 2009). As a result, gait quality impairments may include altered lower extremity joint 
motions, and decreased walking speed, cadence, and step length (Baker et al., 2009; Ries et al., 
2015; Schwartz & Rozumalski, 2008). Joint motions may be excessive or restricted, and/or timed 
differently in comparison to normal gait (Gage & Schwartz, 2009; Gage & Stout, 2009).  
Potential consequences of poor gait quality include increased energy costs, impaired 
function (e.g., difficulty keeping up with peers), poor balance, and long-term musculoskeletal 
stresses and pain (Gage & Schwartz, 2009; Gage & Stout, 2009). Over time, abnormal tissue 
loading and strain associated with altered gait patterns may contribute to musculoskeletal pain 
and subsequent deterioration or cessation of walking (Bleck, 1987; Bottos, Feliciangeli, Sciuto, 
Gericke, & Vianello, 2001; R Jahnsen, Villien, Egeland, Stanghelle, & Holm, 2004; Reidun 
Jahnsen, Villien, Aamodt, Stanghelle, & Holm, 2004; Murphy, Molnar, & Lankasky, 1995; 
Opheim, Jahnsen, Olsson, & Stanghelle, 2009; Steele, DeMers, Schwartz, & Delp, 2012).  
For example, the foot is one of the most common sites of pain in adults with CP (Bleck, 
1987). In a survey of 406 adults with CP in Norway, 44% of respondents reported foot pain 
(Jahnsen et al., 2004), and in another survey of 149 participants, 50% reported foot pain (Opheim 
et al., 2009). The foot may be a common site of pain in individuals with CP owing to the 
prevalence of distal lower extremity spasticity and gastrocnemius contracture, as well as gait 
patterns and foot deformities that impose abnormal biomechanical stresses at the foot during gait 
(Kadhim & Miller, 2014; Sees & Miller, 2013). For example, equinus gait affects approximately 
60% of ambulatory children with CP (Wren, Rethlefsen, & Kay, 2005), and planovalgus foot 
deformity, which is often associated with equinus gait and gastrocnemius contracture, is the most 
common foot deformity in this population (Sees & Miller, 2013). When gastrocnemius 
contracture limits ankle dorsiflexion range of motion (ROM), compensatory motion is required 
for gait, and this is often achieved by midtarsal dorsiflexion accompanied by subtalar pronation 
(Karas, 2002), as seen in pes planovalgus. Excessive midfoot dorsiflexion can disrupt the foot’s 
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ability to function as a rigid lever in late stance and pre-swing, thereby reducing ankle power, 
and can contribute to the development of pain associated with excessive pronation or midfoot 
break (Gage & Schwartz, 2009; Karas, 2002; Maurer et al., 2013). 
Gait quality varies widely between children, depending on the location and extent of the 
neurological injury, and the effects of that injury (e.g., abnormal muscle tone, impaired balance 
and motor control, deformity; Gage & Schwartz, 2009; Novachek et al., 2009). Although the 
brain injury associated with CP is static, the appearance and quality of a child’s gait changes 
over time– with growth or with interventions like surgery or orthoses (Gage & Schwartz, 2009; 
Johnson, Damiano, & Abel, 1997; Wren, Rethlefsen, & Kay, 2005).  
2.2 Types of AFOs for Children with CP 
A variety of orthoses can be useful for children with neurological impairments. Custom-
made AFOs are frequently prescribed in clinical practice to address an individual’s 
biomechanical and neurological impairments and improve walking performance. For example, a 
Swedish study reported that at least half of children with CP wear AFOs, with the most common 
purposes being to improve function and/or increase or maintain range of motion (Wingstrand et 
al., 2014). Several styles of AFO (e.g., solid, hinged) and design options (e.g., trim-lines, 
strapping configurations, AA-AFO) are used, each with different biomechanical effects, intended 
to be selected to match the individual child’s needs.  
Solid AFOs are fabricated as a single piece with plastic spanning the ankle joint, intended 
to prevent sagittal and frontal plane motion of the ankle, as well as subtalar joint and foot motion 
(Figure 1.1A-C). They are designed to prevent motion by applying forces at three points – 
directly at the level of the joint to be stabilized, and proximal and distal to it (Meadows, Bowers, 
& Owen, 2008). Carbon ribs or folds can also be added to reinforce the ankle joint. The AA-
AFO is typically set at 90˚ (Figure 1.1A) but can also be set in some degree of plantarflexion 
(Figure 1.1B). Depending on whether the plastic is trimmed distal or proximal to the MTP 
(metatarsophalangeal) joints, the AFO can restrict or allow MTP extension in terminal stance and 
preswing. To help harness the ground reaction force (GRF) in stance, directing it to the anterior 
tibia to assist knee extension, a Saltiel design GRF AFO (with a pretibial shell and strapping  
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A.           B.        C.  
D.           E.         F.  
G.    
Figure 1.1. Common types of AFOs: A. Solid AFO with 90˚ AA-AFO; B. Solid AFO with AA-
AFO in 10˚ plantarflexion; C. Ground reaction force AFO; D. Hinged AFO; E. Energy storage 
and return AFO; F. Semi-flexible plastic commercial AFO (Flexisport, Cascade DAFO, 
Ferndale, WA); G. Carbon fiber AFO ToeOFF carbon composite dynamic floor reaction 
orthosis, Allard USA, Rockaway, NJ).   
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behind the calf; Figure 1.1C) may be used (Harrington, Lin, & Gage, 1984), or a solid AFO may 
be fabricated with an anterior tibial shell that is attached using Velcro straps. 
Another type of AFO is a hinged or articulated AFO (Figure 1.1D). These are composed 
of two sections – one for the shank segment and one for the foot, with medial and lateral joint 
components connecting the two sections. The joints are intended to be aligned with the axis of 
the talocrural joint, to allow sagittal plane motion while limiting motion in the frontal plane. 
They can be designed to limit plantarflexion, by using a plantarflexion stop, often limiting 
plantarflexion beyond 90⁰ while allowing dorsiflexion. Joint components that assist dorsiflexion 
motion can be employed to compensate for weakness of the ankle dorsiflexor muscles. 
Solid and hinged AFOs are often custom-fabricated from polypropelene. The plastic is 
heated to around 200⁰ Celsius, then drape-formed and vacuum molded over a 3-dimensional 
positive plaster model that has been created by casting or electronically scanning the child’s 
lower leg and foot (Supan, 2008). The plastic is usually 3/16” (4.8mm) thick, but other 
thicknesses may be used depending on the amount of stiffness required to resist the forces 
applied by the child during gait. Semi-flexible AFO styles allow the AFO to bend at the ankle or 
other areas, either through the material properties or by trimming the orthosis posterior to the 
malleoli. Some are designed to store energy during stance and release it to aid propulsion or 
allow a more normal gait pattern. Examples include posterior leaf spring AFOs, energy storage 
and return AFOs, and commercially available orthoses made from plastics (e.g., Flexisport, 
Cascade DAFO, Ferndale, WA) and carbon fiber (e.g., ToeOFF carbon composite dynamic floor 
reaction orthosis, Allard USA, Rockaway, NJ; Figure 1.1E., F., G). 
Although numerous laboratory studies have shown that AFOs can improve aspects of gait 
quality such as step length and velocity, these research findings cannot be generalized to clinical 
situations (Bowers & Ross, 2009); most samples are quite small, heterogenous and poorly 
described, and the analyses focus on mean results. This is problematic because the mean is 
unlikely to be meaningful in the presence of the high intra-individual variability observed in 
individuals with CP; when some children improved, and some got worse, reporting only the 
mean can obscure important differences in how individuals responded to an intervention 
(Damiano, 2014). Most studies of AFOs have not been designed to examine the effects of 
elements of the prescription such as AFO type on individual children and they provide little 
information about the characteristics of the orthoses or the individual participants. Therefore, 
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results attained in research and clinical settings may not be analogous or applicable across 
settings. While clinically prescribed AFOs may improve some aspects of walking such as 
dorsiflexion kinematics and stride length (Hayek et al., 2007), authors of a large cohort study 
reported that 63% of the clinical AFO prescriptions failed to optimize gait quality, and predicted 
that a change in prescription (e.g., AFO type) would have significantly improved the child’s gait 
quality (Ries et al., 2014). Results of a smaller study showed that children may walk less in the 
community when they wear their AFOs, compared to when they wear shoes alone (Bjornson et 
al., 2016). These are important findings, given the numbers of children who wear AFOs and the 
resources invested in this intervention. Therefore, further study is needed in order to understand 
how to optimize a child’s prescription to improve the match between the child and the orthosis. 
2.3 Biomechanical Effects of AFOs for Children with CP 
AFO use can benefit walking in multiple ways, including increased step length and 
velocity, better balance, and improved joint and segment motion (Bowers & Ross, 2009; 
Figueiredo et al., 2008; Morris, 2002; Ries et al., 2015). With respect to joint kinematics, AFOs 
are thought to primarily affect the foot and ankle, although proximal effects (e.g., increased hip 
and knee extension) have been described during stance phase (Butler & Nene, 1991; Eddison & 
Chockalingam, 2013; Jagadamma et al., 2010, 2015; Owen, 2010). These effects are primarily 
reported in the sagittal plane (ankle dorsi-/plantarflexion, hip and knee flexion) (Bowers & Ross, 
2009), likely because this is the plane in which most gait cycle motion occurs, and the plane in 
which its design gives it the greatest leverage.  
The ankle plantarflexor muscles play a key role in both the stance (weightbearing) and 
swing (non-weightbearing) phases of the gait cycle. During stance phase, controlled gait is 
dependent on the alignment of the ground reaction force vector (GRFv) relative to the lower 
extremity joints (Butler, Thompson, & Major, 1992; Eddison & Chockalingam, 2013; Meadows, 
2014). As the plantarflexors control the forward progression of the body over the foot, they also 
prevent collapse of the weightbearing leg by controlling the location of the GRFv (Arnold, 
Anderson, Pandy, & Delp, 2005; Perry & Burnfield, 2010). The actions of these muscles in 
terminal stance and preswing are not fully understood, but it appears that tension developed in 
these muscles during eccentric contraction is key to forward progression and transition into 
swing phase (Fukunaga et al., 2001; Neptune, Kautz, & Zajac, 2001; Perry & Burnfield, 2010). 
Assuming adequate ankle dorsiflexion range of motion, timely relaxation of the plantarflexors 
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also allows the swinging foot to clear the floor in preparation for the subsequent step (Novachek 
et al., 2009). Therefore, neurological conditions that impair plantarflexor muscle function (such 
as CP) can hinder mobility by impairing postural control, resulting in undesirable lower limb 
movements, which may be amenable to AFO intervention.  
By encompassing the foot and lower leg, a solid AFO aims to stabilize the ankle joint, 
compensating for abnormal plantarflexor muscle function and controlling some of these gait 
deviations. For example, it may prevent excessive plantarflexion in the case of plantarflexor 
spasticity or inadequate flexibility; it may also maintain a position of adequate plantarflexion 
(i.e., prevent dorsiflexion or crouching) and generate a plantarflexing moment when the 
plantarflexor muscles are weak (Davids et al., 2007). Excessive dorsiflexion or plantarflexion 
motion during stance phase moves the GRFv farther anterior or posterior to the lower extremity 
joints, contributing to abnormal joint moments, strain, and inefficiency.  By redirecting the 
GRFv closer to the lower extremity joints vertically, a well-designed AFO can promote stability 
and improve gait (Butler & Nene, 1991).  
The greatest benefits of orthotic intervention are thought to be conferred when brace design 
is optimally tailored to address the individual child’s physical impairments (e.g., lower extremity 
joint flexibility, abnormal muscle tone, bony deformity) and walking pattern (Davids et al., 2007; 
Harlaar et al., 2010; Owen, 2010, Owen, 2015). Ideally, the mechanical properties of the brace 
will control the abnormal forces (resulting from the child’s neurological impairments), 
optimizing the resultant joint motions and producing a more normal gait pattern (Butler & Nene, 
1991; Novacheck, 2008; Owen, 2010). Therefore, the effectiveness of an AFO prescription on 
gait quality may be evaluated by objectively describing the child’s gait pattern, and quantifying 
the extent to which it differs from normal, with and without the AFO (Galli, Cimolin, Rigoldi, & 
Albertini, 2016). 
2.4 AFO-Footwear Combination Tuning  
AFO-Footwear Combination (AFO-FC) tuning involves the biomechanical optimization of 
the AFO-FC for a specific activity, such as walking (Bowers & Ross, 2009; Eddison & 
Chockalingam, 2013; Meadows, 2014; Owen, 2018). The shank to vertical angle (SVA) of the 
AFO-FC may be tuned or adjusted  to optimize the alignment of the GRFv relative to the lower 
extremity joints (Jagadamma, 2010; Novachek et al., 2009; Owen, 2004a, 2010). This may 
involve adapting the heel or sole (e.g., using heel flares, heel wedges, or toe rockers) (Owen, 
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2004b, 2010). If the AFO is sufficiently rigid, tuning may improve stance phase stability by 
altering external joint moments (Bowers & Ross, 2009; Butler et al., 1992; Eddison & 
Chockalingam, 2013; Meadows, 2014; Morris et al., 2011; Owen, 2010; Pratt, Durham, & 
Ewins, 2007).  
While tuning has been recommended to improve lower extremity kinematics in children with 
CP (Bowers & Ross, 2009; Eddison & Chockalingam, 2013; Jagadamma et al., 2015), the 
process is not well-utilized in practice, nor are its effects fully understood (Eddison, 
Chockalingam, & Osborne, 2015; Meadows, 2014). In typical gait, the shank is reclined relative 
to vertical at initial contact (IC), and then inclines progressively throughout midstance as the 
ankle dorsiflexes. This gradual increase in shank incline facilitates forward progression, allowing 
the body’s centre of mass to continue to move forward, and the centre of pressure to progress 
distally along the foot; however, a solid AFO is designed to prevent this ankle motion, so it 
likely impairs this aspect of gait. Compounding this problem, AFO-FCs are typically aligned to 
produce a vertical tibia at temporal midstance (TMSt), even though the tibia normally inclines to 
approximately 10˚ at that point in the gait cycle for adequate stability in stance (E Owen, 2010; 
Tilley & Associates, 1993). Therefore, the typical alignment of an AFO-FC with a solid AFO 
(with a 90˚ AA-AFO and 0˚ to 5˚ forward pitch in the shoe) may induce compensatory gait 
strategies to progress forward while walking. Thus, gait impairments may be created or 
exacerbated by the biomechanical restrictions imposed by the AFO-FC. 
Shank kinematics and the SVA provide another – perhaps more direct way – to view the 
effects of AFOs on gait kinematics. Many studies focus on ankle, knee and hip joint kinematics 
as an indication of AFO efficacy (Bowers & Ross, 2009); but the effect of an orthosis on knee 
and hip joint motion is indirect. Because of the direct effect of the AFO-FC on the SVA, and the 
direct influence of the SVA on lower extremity joint moments, the SVA at TMSt may be another 
meaningful outcome (Eddison, Healy, Needham, & Chockalingam, 2017; Jagadamma et al., 
2010, 2015; Kerkum, Houdijk, et al., 2015; Meadows et al., 2008; Owen, 2010; Pratt et al., 
2007). Normative SVA values have been studied in a small number of typically developing 
children (Pratt, 2007), and a few authors have reported optimal SVAs in populations with 
neurological impairments (Eddison et al., 2017; Eddison & Chockalingam, 2013; Jagadamma et 
al., 2009; Nuzzo, 1986; Owen, 2004a). Owen has also published guidelines for AFO intervention 
based on SVA (Owen, 2010), although these have not been tested empirically.  
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A small but growing body of evidence supports the use of tuning for children with 
neurological conditions like CP; however, these studies are typically of low methodological 
quality – tending to be small and lack key details about the orthoses, participants, and 
methodology (Eddison, Mulholland, & Chockalingam, 2017; Eddison & Chockalingam, 2013; 
Ridgewell, Dobson, Bach, & Baker, 2010). Tuning is not yet standard practice, possibly due to 
barriers relating to inadequate research evidence and clinician knowledge (Eddison et al., 2015). 
Yet, tuning has been recommended for individuals wearing AFOs following stroke (National 
Health Service Quality Improvement Scotland, 2009) and children with CP who wear solid 
AFOs (Bowers & Ross, 2009; Meadows, 2014). For children with CP, some of the effects of 
tuning include reduction of knee hyperextension for children with extended knee or jump knee 
gait patterns (Jagadamma et al., 2015). Two studies (Butler, Farmer, Stewart, Jones, & Forward, 
2007; Jagadamma et al., 2015) reported that the effects of tuning depended on the child’s gait 
pattern at the knee. Butler and colleagues (2007) found that children whose AFOs could be 
successfully tuned showed 20˚ of knee flexion or less in the first third of stance followed by 
extension to 10⁰ or less in the second third of stance. However, neither paper included details 
about the AFOs, such as the AA-AFO. 
2.5 Methodology – Measuring the Effects of an AFO  
2.5.1 Laboratory methods of orthotic evaluation 
Published research studies have provided a variety of information about the effects of 
AFOs for children with CP. This data has primarily been collected in laboratory studies using 
three-dimensional gait analysis (3DGA) to examine variables including kinematics (e.g., ankle, 
knee, hip, and shank) and kinetics (e.g., GRF, ankle, knee and hip), spatiotemporal variables 
(velocity, step length, cadence), muscle excursion (using muscle length modelling) (Choi, Wren, 
& Steele, 2017; Choi, Wren, & Steele, 2014), or EMG (Lam, Leong, Li, Hu, & Lu, 2005; 
Radtka, Skinner, & Johanson, 2005; Rethlefsen, Kay, Dennis, Forstein, & Tolo, 1999; Romkes, 
Hell, & Brunner, 2006; Romkes & Brunner, 2002; Wren, Rethlefsen, & Kay, 2005). Wearable 
sensors and instrumented walkways have also been used to obtain spatiotemporal gait data. The 
effect of AFOs on function has been assessed using tools like the Timed Up and Down Stairs 
(Sienko Thomas, Buckon, Jakobson-Huston, Sussman, & Aiona, 2002), and the Pediatric 
Balance Scale (Kott & Held, 2002).  
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The gold-standard for quantifying gait impairments, and evaluating spatio-temporal 
variables, kinematics, and kinetics is instrumented 3DGA. Kinematic and kinetic data can be 
plotted for one or more gait cycles, and curves can be visually compared between conditions 
(e.g., barefoot, shoes, AFO) or with normative data; or meaningful discrete values can be 
calculated and compared (e.g., peak knee flexion in stance; velocity). Gait quality summary 
measures (e.g., Gillette Gait Index (Schutte, Stout, Gage, & Selber, 1997; Wren et al., 2007), 
Gait Deviation Index (Schwartz & Rozumalski, 2008), and Gait Profile Score (Baker et al., 2009; 
Beynon, McGinley, Dobson, & Baker, 2010)) can also be calculated by comparing data from 
3DGA to normative reference values. Such indices seek to provide a concise measure of gait 
quality that objectively quantifies the overall severity of the gait problem (Cimolin & Galli, 
2014), or to monitor changes over time or in response to treatment (Baker et al., 2009). Although 
gait observation is a daily function for mobility experts such as physical therapists, doctors, and 
orthotists, 3DGA requires significant resources, equipment, and expertise, and is rarely 
accessible to clinicians (Toro, Nester, & Farren, 2003a). Furthermore, these global indices may 
not be specific enough to identify the effects of focussed orthotic intervention on isolated, yet 
targeted, gait parameters such as ankle kinematics (Danino et al., 2012; Galli et al., 2016).  
2.5.2 Clinical methods of orthotic evaluation  
Clinicians lack a simple means to describe walking patterns, identify deviations, and 
monitor change in order to evaluate the effects of AFO intervention with accuracy and specificity 
(Rathinam, Bateman, Peirson, & Skinner, 2014). Currently, observational gait assessment – 
performed using either the unaided eye or video recording – is the most common means of 
identifying and describing gait deviations and impairments in clinical environments (Toro et al., 
2003b). Gait observation is readily applied in clinical practice, as it is quick, requires little space, 
and does not use specialized equipment (Krebs, Edelstein, & Fishman, 1985; Toro et al., 2003a). 
It is typically approached in an unsystematic fashion, without standardized protocols or 
checklists (Toro et al., 2003a). Despite its wide popularity, gait observation is subject to observer 
bias and error, and therefore its reliability and its validity with respect to 3DGA have been 
questioned (Coutts, 1999; Kawamura et al., 2007; Krebs et al., 1985; Maathuis, van der Schans, 
van Iperen, Rietman, & Geertzen, 2005; Toro et al., 2003a; Toro et al., 2003b). 
 The challenges of accurately observing the complex motions of live, pathological gait in a 
clinical setting are likely associated with physiological error, incurred as the visual system infers 
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2-dimensional information from a 3-dimensional context (Lappin & Fuqua, 1983). This error is 
likely compounded by the speed of human visual tracking with respect to the complexity and 
constant multiaxial motion of abnormal gait (Bahill & McDonald, 1983; Krebs et al., 1985). 
Parallax error, or the discrepancy between the observer’s line of sight and the plane of motion 
may also contribute (Deluca, Davis, Ounpuu, Rose, & Sirkin, 1997; Kawamura et al., 2007). For 
instance, an observer may underestimate the amount of flexion at the knee (sagittal plane) when 
there is excessive concurrent hip internal rotation (transverse plane) (Deluca et al., 1997). 
 Standardized checklists (e.g., the Physicians Rating Scale (Koman, Mooney, Smith, 
Goodman, & Mulvaney, 1993) and its subsequent iterations (Boyd & Graham, 1999; Mackey, 
Lobb, Walt, & Stott, 2003), the Salford Gait Tool (Toro, Nester, & Farren, 2007a), and the 
Edinburgh Visual Gait Score (EVGS; Read, Hazlewood, Hillman, Prescott, & Robb, 2003) are 
thought to improve the accuracy and consistency of gait observation (Bella, Rodrigues, 
Valenciano, Silva, & Souza, 2012; Brown, Hillman, Richardson, Herman, & Robb, 2008; 
Dickens & Smith, 2006; Ferrarello et al., 2013; Gupta & Raja, 2012; Hillman et al., 2010; 
Hillman, Hazlewood, Schwartz, van der Linden, & Robb, 2007; Mackey et al., 2003; Ong, 
Hillman, & Robb, 2008; Read et al., 2003; Toro et al., 2003a; Toro, et al., 2007a; Toro et al., 
2007b). Yet, within the literature examining the psychometric properties of these scales, 
estimates of reliability and validity vary widely − even between similar items on different scales. 
For example, while Read and colleagues (2003) reported 83% agreement between 3DGA and 
ratings of maximum ankle dorsiflexion in swing, Kawamura and colleagues ( 2007) found very 
low kappa scores (0.01-0.10) for the nearly-identical item, dorsiflexion at IC. Similarly, this first 
study (Read et al., 2003) reported near-perfect agreement between 3DGA and 64% of numerical 
items on the EVGS; while the latter (Kawamura et al., 2007) concluded that ratings of only two 
gait variables (pelvic obliquity and knee flexion at IC) were valid. Yet, gait observation is a 
fundamental clinical tool, and gait scales provide a means to modestly improve the objectivity 
and standardization of gait analysis compared to unstructured observation alone.  
Despite inconsistencies across different scales, there is evidence that certain elements of gait 
can be reliably and accurately observed, given the right conditions. McGinley (2003) concluded 
that when attention is focussed on a single gait variable (i.e., ankle power in adults following 
stroke), and the task is clearly defined, therapists can make accurate and reliable judgements 
from a gait video. Other authors have reported that numeric items (e.g., using degree or degree-
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based categories to rate joint position; Grunt et al., 2010; Hillman et al., 2010), and gait events in 
the sagittal plane (Coutts, 1999; Krebs et al., 1985; Mackey et al., 2003; Read et al., 2003) may 
be most reliably rated. Other factors that may improve the reliability and validity of gait 
observations include: high quality video (Dickens & Smith, 2006; Fatone & Stine, 2015; Harvey 
& Gorter, 2011; Wren, Rethlefsen, Healy, et al., 2005), video analysis software (Borel, 
Schneider, & Newman, 2011; Grunt et al., 2010), clear definitions of scale items (Mackey et al., 
2003), standard rater education about normal gait kinematics (Krebs et al., 1985), standardized 
camera views (e.g., orthogonal views in line with the camera’s optical axis; Fatone & Stine, 
2015), and subject preparation methods such as tight-fitting clothes and markings on the skin 
over anatomical landmarks (Fatone & Stine, 2015; Hillman, Hazlewood, Loudon, & Robb, 1998; 
Viehweger et al., 2010).  
2.6 Overview of Current AFO Prescription Processes in Canada 
AFO prescription (including evaluation and determination of the prescription, and follow-
up) ideally involves the child and family, physician, certified orthotist, and physical or 
occupational therapist (Uustal, 2008). In Canada, where health is a provincial responsibility, 
provincial governments determine the types of orthoses that will be funded or partially funded, 
the criteria for each type of orthotic device, and the conditions (including the frequency) under 
which they can be prescribed and dispensed (e.g., Government of Saskatchewan, 2018).  In 
Saskatchewan, AFOs must be requisitioned by a physician and most are fabricated and dispensed 
by orthotists at two publicly-funded facilities (Government of Saskatchewan, 2016). These 
centres provide tertiary service to the province. There are also a small number (<5) of private 
orthotists, though only one or two provide (infrequent) services to children with CP. Follow-up is 
typically provided by the primary care provider/community therapist, in conjunction with the 
team at the tertiary facility (Government of Saskatchewan, n.d.). Although many aspects of the 
AFO prescription process could affect the success of the intervention, this process (including 
aspects such as which disciplines are involved, the timing of involvement, and the role of each 
provider) has not been described in the literature. Furthermore, if best practice guidelines are to 
be developed for AFO prescription, they would need to be implemented within this context.  
With respect to gait quality, the efficacy of AFO intervention may fall short of its potential 
(Ries et al., 2014, 2015). The reasons behind this are not understood; however, it is likely that 
 16 
 
developing a valid and reliable means of clinical gait evaluation specific to AFO intervention is 
an important step toward more efficacious prescription. Recent evidence (Ries et al., 2014), 
highlights a lack of evidence-based guidelines and outcome measures for AFO prescription and 
evaluation. Instead, the process appears to be guided by clinical opinion, preference, and trial and 
error (Morris, Newdick, & Johnson, 2002). While objective and accurate documentation of 
treatment goals and progress has been recommended for effective AFO provision (Davids et al., 
2007), it is not clear whether goal-setting occurs consistently (Ries et al., 2015), or how – or 
even if  – outcomes are assessed.  
2.7 AA-AFO 
Although plantarflexor muscle flexibility greatly affects gait, determination of the optimal 
angle at which to position the ankle within an AFO (i.e., the AA-AFO) has not been explored 
(Eddison & Chockalingam, 2013; Jagadamma et al., 2015; Owen, 2010). AFOs are traditionally 
fabricated with the child’s ankle at a 90˚ angle in the sagittal plane.  This is typically done with 
the intention of stretching the spastic plantarflexor muscles and preventing deformity; however, 
there is insufficient evidence to support this practice (Eddison & Chockalingam, 2013; Morris et 
al., 2011). Furthermore, for children with equinus, these muscles (which span the knee, ankle and 
hind-foot joints) may lack the length or flexibility to allow the ankle and foot to achieve this 
position without compromise. Even if the child’s ankle can be forced to a 90˚ angle while at rest 
during an examination, spastic muscles are stiffer than typical muscles, and muscular activity 
increases excessively with the physical effort of walking (Van Der Krogt, Doorenbosch, Becher, 
& Harlaar, 2010). 
When an AFO’s form requires greater flexibility of the plantarflexor muscles than the child 
has, as in the case of a 90˚ AA-AFO for a child with equinus, the ankle motion required to wear 
the brace often occurs at the expense of other tissues and walking is uncomfortable. Activation of 
the fully lengthened muscles is impaired (Lieber, 2002), and gait compensations may include an 
inability to straighten the knee, altered foot contact with the floor, and compromised foot posture 
(Owen, 2010; Ridgewell et al., 2010). Children may also be less likely to wear their AFOs if they 
are uncomfortable or hinder mobility. Given that mobility optimization and deformity prevention 
are two key reasons for AFO prescription for children with CP (Novachek et al., 2009), the 
consequences of orthotic non-compliance or AFO-induced deformation may be significant.   
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As an alternative to the conventional 90˚ AA-AFO, Owen (2005, 2010). describes a 
method for determining an individualized AA-AFO that reflects calf muscle function during the 
dynamic task of walking and is based on clinical measures of the child’s plantarflexor muscle 
length and stiffness. This approach has not been examined in an experimental setting. 
2.8 Gaps in the Literature 
As with many areas in rehabilitation, there are challenges with conducting high-quality 
research on AFO prescription for children with CP, and numerous gaps exist. Populations are 
heterogenous, and problems are multifactorial. Studies often report the means of select variables 
for the group of children with CP; however, for diverse populations such as children with CP, the 
mean is likely to represent a variety of responses to the intervention, and therefore is not 
meaningful (Damiano, 2014). As a clinician’s role is to tailor the intervention to an individual 
child, research evidence may be more meaningful if studies described the observed variation or 
strove to understand individual responses to intervention. Gait impairments in CP are not well 
understood, and the factors impacting a child’s response to an AFO are unknown. Furthermore, 
the characteristics of the orthoses and participants are often not fully described in the literature, 
making it difficult to generalize and interpret the results for clinical purposes (Bowers & Ross, 
2009; Ridgewell et al., 2010). Most studies have not incorporated tuning and biomechanical 
optimization, possibly affecting study outcomes, and making comparisons difficult. These 
factors (among others) suggest a lack of evidence to guide clinical AFO prescription practice.  
Clinical AFO prescription appears to face several challenges - perhaps in part because of the 
state of the evidence - although these have not been described in detail. Variable practices have 
been described, reliant on subjective judgements and local experience rather than objective 
evaluation and biomechanical rationale (Morris et al., 2002; National Health Service Quality 
Improvement Scotland, 2009). Research evidence seems inadequate to allow prescriptions to be 
based on biomechanical principles. In the absence of evidence, some conventional practises – 
such as the ubiquitous 90˚ AA-AFO – appear to contravene biomechanical reasoning.  
As such, the outcomes of AFO prescription have the potential to be aided by evidence-based 
guidelines. Key steps toward improving clinical outcomes and furthering orthotic research are: 1) 
to describe the present state of AFO prescription for children with CP, and 2) to begin to 
understand the biomechanical effects of key aspects of the AFO prescription, such as the AA-
AFO.   
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CHAPTER 3: CLINICIAN PERSPECTIVES AND EXPERIENCES IN THE PRESCRIPTION 
OF ANKLE-FOOT ORTHOSES FOR CHILDREN WITH CEREBRAL PALSY 
Manuscript re-published with permission and edited from its original form. Original citation:  
Kane, K., Manns, P., Lanovaz, J., & Musselman, K. (2018). Clinician perspectives and 
experiences in the prescription of ankle-foot orthoses for children with cerebral 
palsy. Physiotherapy Theory and Practice, 1-9. 
 3.1 Abstract 
Purpose: Physiotherapists, orthotists, and physicians are involved in the prescription of 
ankle-foot orthoses (AFOs) for children with cerebral palsy (CP); however, little is known 
about how prescription decisions are made in practice. Therefore, the study objective was 
to identify current AFO prescription and clinical decision-making practises for children 
with CP in Canada. Methods: Focus groups were conducted in five pediatric rehabilitation 
facilities, with 32 clinicians. Semi-structured interviews focused on the goals and types of 
AFOs used, referral and follow-up processes, and clinical evaluation measures. Interpretive 
Description was used as a framework for analysis. Transcribed dialogue was imported into 
NVivo 11 for data coding and analysis. Three researchers participated in coding to 
establish categories and themes. Results: Categories included: what is made, how it is 
used, and factors that either support or challenge outcomes. Strengths and challenges of the 
current prescription process were discussed, including funding, communication, and 
technology to enhance clinical evaluation. Throughout the interviews, the theme of 
prescription as a collaborative, iterative, and individualized process emerged. Conclusions: 
Processes, strengths, and challenges associated with AFO prescription in Canada were 
identified. This is a first step toward the development of guidelines to help clinicians 
improve AFO prescription for children with CP.  
KEYWORDS: clinician decision-making; interpretive description; cerebral palsy; ankle-
foot orthoses; orthotic prescription 
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3.2 Introduction 
Cerebral palsy (CP) is a neurodevelopmental disorder of movement and postural control 
that is caused by a disturbance to the developing infant or fetal brain (Rosenbaum et al, 2007). 
While approximately 2/3 of children with CP attain some independent walking ability (Pharoah 
et al, 1998), gait impairments vary depending on the location and extent of the neurological 
injury, and the resultant impairments (e.g., abnormal muscle tone, impaired balance and motor 
control, deformity) (Gage & Schwartz, 2009). Children with CP may experience limitations 
across all domains of the International Classification of Functioning, Disability and Health (ICF) 
framework (World Health Organization, 2016a), including body structures and functions, (e.g. 
spasticity), activity (e.g., mobility), and participation (e.g., attending school) (Schiariti & Masse, 
2015; World Health Organization, 2016b). 
Custom-made walking braces called ankle-foot orthoses (AFOs) are frequently 
prescribed for children with CP, to address biomechanical and neurological impairments, and 
improve walking performance. AFO intervention is known to improve several aspects of gait, 
such as mechanics, step length, and velocity (Bowers & Ross, 2009); however, the greatest 
benefits appear to be conferred when brace design is optimally tailored to the individual child’s 
physical impairments and gait pattern (Davids, Rowan, & Davis, 2007; Harlaar et al, 2010; 
Owen, 2010, 2015). Ideally, the mechanical properties of the brace will control the abnormal 
forces (which result from the child’s neurological impairments), optimizing the resultant joint 
motions and producing a more normal gait pattern (Butler & Nene, 1991; Novacheck, 2008; 
Owen, 2010). 
Although numerous studies and reviews have reported the benefits of AFOs in research-
based laboratory settings (Bowers & Ross, 2009; Morris et al, 2011), AFOs may not achieve the 
same standard of effectiveness in clinical practice. As an example, Ries, Novacheck and 
Schwartz (2014) reported that only 37% of AFO prescriptions in a clinical sample maximized the 
child’s gait quality, and 28% of the prescriptions negatively impacted gait pattern. The same 
group (Ries, Novacheck, & Schwartz, 2015) reported that increased step length was the only 
consistent, clinically-significant benefit of AFO use, and suggested that clinicians require a more 
effective approach to AFO prescription. However, to date, the perceived challenges and 
opportunities associated with clinical AFO prescription have not been examined, and little is 
known about the way prescription decisions are made in clinical settings. 
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When prescribing and designing an AFO, clinicians choose from numerous types of 
orthoses (e.g., solid ankle, hinged) and design options (e.g., strapping, trim-lines), in order to 
deliver the optimal orthosis for each child (Davids, Rowan, & Davis, 2007). Current research 
focuses broadly on CP subtype (e.g., hemiplegia, diplegia) and gait pattern (e.g., patterns of knee 
involvement, and hemiplegic gait patterns; Sutherland & Davids, 1993; Winters, Gage, & Hicks, 
1987), as the factors determining AFO selection (Bowers & Ross, 2009; Radtka, Skinner, & 
Johanson, 2005). While a few authors advocate that individual factors (e.g., each child’s range of 
motion) should influence the prescription (Davids, Rowan, & Davis, 2007; Owen, 2010; 
Ridgewell, Dobson, Bach, & Baker, 2010), specific evidence-based guidelines are lacking 
(Harlaar et al., 2010; Ries, Novacheck, & Schwartz, 2014). Instead, the process appears to be 
guided by subjective clinical opinion and prescriber preference (Morris, Newdick, & Johnson, 
2002). While objective and accurate documentation of treatment goals and progress has been 
recommended for effective AFO provision (Davids, Rowan, & Davis, 2007), goals and goal 
attainment are generally not reported in the literature (Ries, Novacheck, & Schwartz, 2015). The 
extent to which objective measures are used to evaluate the effectiveness of the AFOs that are 
prescribed is also unclear.  
Therefore, the purpose of this qualitative study was to learn about the experiences of 
clinicians, in order to identify current AFO prescription and clinical decision-making practices. 
As this topic has not been examined previously, qualitative methodology was considered the 
most effective way to explore and gain a first-hand understanding of current practices, as well as 
the perceived challenges associated with AFO prescription.  
3.3 Methods 
3.3.1 Design 
Interpretive Description (Thorne, Reimer Kirkham, & MacDonald-Emes, 1997) provided 
a framework for this study. As a grounded approach to conducting qualitative health research, 
Interpretive Description extends beyond simple description to examine meanings and 
explanations underlying participants’ experiences (Thorne, Reimer Kirkham, & O’Flynn-Magee, 
2004). It aims to produce a new interpretation of a complex clinical experience and can help to 
inform practice (Thorne, et al., 2004). The study was approved on ethical grounds by the 
Research Ethics Boards of the University of Saskatchewan and Regina Qu’Appelle Health 
Region. 
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3.3.2 Participants 
Purposive, convenience sampling was used to select rehabilitation centres that provide 
primary (within health region) and tertiary (outside of region) orthotic care to children under a 
publicly-funded, single payer health system (including physician, orthotic, and physical therapy 
services). This strategy was anticipated to facilitate access to potential participants who could 
provide rich, meaningful data that would be relevant to the study purpose (Milne and Oberle, 
2005; Morse, 2015). Five rehabilitation centres in four Canadian provinces participated. A 
physical therapist (PT) at each facility invited all physical therapists, orthotists, and physicians 
involved in AFO prescription for children with CP at the centre to take part in the focus group.   
Participants were 4 physiatrists, 17 physical therapists, 10 orthotists, and 1 kinesiologist. 
Within the group, clinical experience in pediatrics ranged from 1 year to 39 years.  
3.3.3 Data collection 
One or two of the researchers (KJK and/or KEM) conducted an in-person focus group at 
each participating centre. Both researchers were present at two interviews, and due to the need to 
travel, the remaining interviews were conducted by one researcher (KJK or KEM). A semi-
structured interview guide was used (table 3.1) and the discussions were audio-recorded. Focus 
group meetings lasted 35-56 minutes and group size ranged from 3-9 participants. Researchers 
wrote field notes and impressions following each meeting, and small modifications to the semi-
structured interview guide were made throughout the data collection process, consistent with an 
interpretative approach.  
3.3.4 Analysis 
Interviews were transcribed verbatim. One researcher (KJK) read the transcripts several 
times and listened to the audio recordings, in order to review the transcripts for accuracy and to 
aid in analysis.  Following member checking (i.e., participant review of the transcript for 
accuracy), transcripts were imported into NVivo 11 for data management, coding, and analysis.  
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Table 3.1. Examples of open-ended questions from the interview guide that were used in the 
focus group meetings  
Sample questions used in semi-structured interviews 
1. What do you see as the purpose of an AFO? What are some typical goals for AFO 
intervention?  
2. What are the most common AFO types and design features your program uses? When 
is each one used?  
3. When determining the prescription for the new AFO, what are the important factors 
or clinical measurements that you consider?  
4. After the child is fitted with the AFO, how is it evaluated or assessed?  
5. What do you think works well in your facility’s current AFO prescription process? 
What factors do you think are important in providing children with AFOs that are 
beneficial to them?  
*Note that additional questions and probes were asked as appropriate to the discussion 
at each facility. 
 
 
Three researchers (KJK, PJM, KEM) then independently coded one transcript deemed to 
contain the richest data. Codes were then discussed as a group. This was done in order to 
inductively derive preliminary categories and themes based on the units of information that made 
up the transcripts (Morse, 2008). Using the preliminary categories, two researchers (KJK and 
KEM) coded the remaining transcripts independently and resolved discrepancies through 
discussion.  
Transcripts were reread several times after initial coding to review interpretations, and 
similarly coded segments were compared to ensure coding definitions were applied consistently 
(Corbin & Strauss, 1990; Hewitt-Taylor, 2001). New codes were added as necessary, and the 
preliminary analytic structure was adjusted several times as data were re-contextualized through 
constant comparative and iterative analysis (Corbin & Strauss,1990; Hewitt-Taylor, 2001; 
Thorne, et al., 2004). Notes were made about how decisions were reached, in order to increase 
credibility (Emden & Sandelowski, 1999; Thorne, et al., 2004) and transparency (Tracy, 2010). 
Once the transcripts had been coded, and preliminary codes and a theme identified, three 
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researchers (KJK, PJM, KEM) discussed the developing analytic structure and the need for 
further adjustments. 
3.4 Results 
Participants described AFO prescription as an iterative, collaborative, individualized 
process. This theme ran through the clinicians’ discussions about their experiences with AFO 
prescription (Figure 3.1). Participants talked about “what is made”, “how it is used”, and topics 
that bridged the spaces between and within these categories. They discussed 
“supports/challenges” that were foundational to the “what” and “how” categories. These 
categories are examined below.   
 
Figure 3.1. Diagram showing relationships between categories. While the orthosis that is made 
(“What is made”) influences its effects (“How it is used”), the effects of the orthosis also impact 
decisions about the revisions and adjustments to the design of the orthosis. As such, the 
bidirectional arrow represents the capacity for the prescription to evolve, which is the essence of 
the theme. 
 
3.4.1 Category 1: What is Made 
Participants discussed the AFOs that are made, and the procedures that are involved in 
prescription. They identified types of information that clinicians consider when determining the 
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initial prescription and as the prescription evolves. The category was comprised of four 
subcategories: What an AFO can do, Types of AFOs, The prescription, and Collaborative goal 
setting. 
3.4.1.1 What an AFO can do 
Participants described the purpose of an AFO as both preventative, and to effect 
therapeutic change. AFOs are “adjuncts to the rest of the treatment” (physician). Using the ICF 
framework, most reported uses were at the level of body structure and function. Here, AFOs 
were thought to help “manage pain”, “control tone”, and facilitate non-weightbearing alignment. 
Participants described using AFOs to maintain range of motion, prevent contracture, deformity, 
and pain over time, and to preserve gains following other interventions. One physician indicated 
that “maybe the AFO doesn’t achieve the goal of preventing contracture, but maybe it slowed it 
down.” A PT indicated that “the absence of a problem…the absence of deteriorating range of 
motion, contracture, and pain” may be interpreted as evidence that an AFO is preventing future 
problems. With respect to activity, AFOs may facilitate weightbearing, position the foot for 
functional activities, improve gait efficiency, and facilitate gait determinants like “clearance 
during swing [and] stability in stance.” The following exchange reflects the way an AFO may be 
used to address multiple goals and ICF levels:  
Orthotist 1: [An AFO may meet] one or all three needs: one would be to help improve 
their gait pattern. Two, maintain or slow progression of loss of range of motion and/or 
[three.] to protect foot and ankle alignment.  
PT: And a fourth to that would be function… Priorities will vary based on client goals, 
family goals, and also client’s abilities, and obviously therapy goals. So the four may 
change in priority, but those are probably the four that I think we look at.  
3.4.1.2 Types of AFOs 
Participants indicated that decisions about which type of AFO to use for a child are 
generally influenced by the child’s goals, and the local group’s experiences, knowledge, and 
preferences. One PT said: “I can’t say that we have really a whole lot of written guidelines and 
protocols. A lot of it depends on the clinical experience of...the practitioners involved.” Another 
said: “I feel like we’re limited by what we’ve always done.… Sometimes I feel like there’s a 
nebulous out there of things that could work, that we just don’t know about.” 
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Differing perceptions amongst therapists, parents, and physicians may also influence the 
type of AFO selected. For example, one physician described conflicting perceptions about 
hinged AFOs: 
Therapists like [hinged braces] because therapists are more interested in activity and 
participation, and hinged braces are better. But for some of us, we are interested in body 
function and body structure, and [a] hinged brace actually selectively over-stretches your 
soleus, which can cause crouch gait. And parents love hinged, they think hinged is 
“higher marks” than a rigid brace… 
3.4.1.3 The Prescription 
The prescription is influenced by the prescribing physician’s habits, preferences, 
“personal comfort level with orthotics, and their knowledge level and interest” (PT). The amount 
of team collaboration varies. For example, PTs who are more comfortable with AFO prescription 
may be “very assertive and say, ‘oh this is what I think they need’” (PT). At one facility, a PT 
commented that “certain [prescribers]… will just provide a prescription [that says only] 
‘orthotic’... And then the orthotist will assess the client and determine [which orthosis] would 
[provide] the best function.” At another centre, the prescription includes “the [AFO type], the 
goal, and usually the range of motion” (orthotist). 
When the orthotist assesses the child, they typically “fill[s] in the gaps” in the 
prescription. The orthotist determines the need to communicate with the team in order to resolve 
discrepancies between their assessment and the prescription, or to make decisions necessary to 
complete the brace design (e.g., the casting position for the foot and ankle, trim-lines, strapping 
configuration, joints, AFO-footwear combination tuning.) Although orthotists “don’t look that 
hard at prescriptions” (orthotist), they are responsible to either fabricate the orthosis according to 
the prescription, or contact the PT or physician “to discuss what [they] think might be better”. 
This judgement is pivotal, as collaboration may trigger improvements to the prescription or alter 
the child’s management plan.  
3.4.1.4 Collaborative goal setting 
Goals are central to the discussion about what will be made. Participants described how 
“a team approach [facilitates] consensus [about] goals” (PT). Although collaboration amongst 
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team members occurs, it was generally described as fragmented and unsystematic. Multi-
disciplinary goal-setting and evaluation were identified as ideals: 
PT: To be able to...have those family team meetings with…everybody involved so that 
physios, physicians, orthotists, family, are all in the meeting discussing…big picture 
goals,…minor goals, and then be able to review them regularly…It would be nice if 
funding would let that happen and we all had time to do it. 
To bolster collaboration, clinicians may make additional efforts to communicate about 
the prescription and goals. For example, PTs sometimes attend the orthotics appointments, “to 
have that communication with the orthotist directly to make sure that the splint is meeting those 
goals, or that we’re having common goals.”  
3.4.2 Category 2: How it is Used 
 In this category, participants described what typically happens after the child gets the 
AFO, how the child uses it, and outcomes. There was one subcategory: Follow-up. 
3.4.2.1 Follow-up 
Prescription involves “trial and error” (PT). Therefore, the PT or orthotist may re-assess 
the AFO after the child receives it.  
PT: [There are] times where you actually have to see the child with the orthosis, to see 
how they’re functioning, to see if the goals are being met .... And if not, are there minor 
adjustments that can be made? And that’s again a collaborative conversation with the 
clinicians. 
Children (and their AFOs) are often reviewed annually by the physician, or sooner if a 
concern is identified by a therapist or family. Reasons to review or revise a prescription include 
growth, discomfort, adverse effects on gait, loss of flexibility, and/or surgery or botulinum toxin 
injection.  
For children who reside long distances from the prescribing centre, efforts to coordinate 
collaborative assessment and intervention are enhanced. “Because they’re coming such a 
distance and we want to…make the best use of their time, our time,…we often ask an orthotist 
to…see the child with us so we can really come up with a firm decision [about the orthotic issue 
or prescription]” (PT).  
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The interdependence of “what is made” and “how it is used” is evident in the flexibility 
of the prescription, as it evolves through clinical re-evaluation. Although the specifics of each 
orthosis will impact how the child uses it, participants indicated that the reverse may also occur. 
That is, the outcome may influence changes in the initial prescription and subsequent 
prescription decisions A subcategory of both category 1 and 2, Evaluation, reflects this process 
(Figure 3.1). 
3.4.2.2 Evaluation 
 Clinical findings influence the initial AFO prescription (“what is made”), as well as any 
subsequent changes once the orthosis has been made. Changes to the AFO during or following 
the fitting are informed by evaluating “how it is used”.  
 Participants reported seeking out subjective feedback, including information about the 
comfort of the AFO, the child’s reliance on it, and satisfaction. As one physician described: “We 
rely on the families to give us a lot of feedback. …What’s working, what’s not working, 
challenges they are facing…”  
 Participants described the information that they collect from the physical examination, 
and the assessment tools (primarily visual and informal) that inform prescription and adjustment 
decisions. Most information was collected at the ICF body structure and function level, including 
skin integrity, alignment, midfoot stability, lower extremity range of motion, muscle tone, 
strength, and selective motor control. At the activity level, balance, and walking distance and 
speed may be evaluated. Most participants visually observe the child’s gait pattern.  
 However, once a child receives the new AFO, assessment may focus more on subjective 
feedback than on objective evaluation of the orthosis: 
PT: Ideally because we’ve usually done a lot [of pre-assessment], we should be doing all 
of that again…But often it doesn’t [happen] for whatever circumstances. [The 
reassessment] ends up being – from the family’s…and the child’s point of view – is it 
working? …Are they happy with it, is it better than before?  
More frequent use of video for gait observation and “problem solving” (PT) was 
identified as an ideal to strive for. Video can facilitate more objective monitoring: “…Kids grow 
and change and I can’t remember what this child looked like a year ago.…If we could see that 
difference [using video] that would be ideal” (physician). Video can also provide a more 
concrete “platform [for parent education],…to help [families] see what you are seeing and break 
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down their concerns.” Challenges associated with privacy, storage and transfer of digital files 
were identified as limitations to the use of video gait analysis. Other limitations related to 
evaluation included: lack of orthoses available for trial, insufficient space for gait assessment, 
and inadequate time and infrastructure to allow collaboration. 
3.4.3 Category 3: Supports/Challenges  
Participants discussed four main factors that either support or challenge the outcomes of 
AFO management. These factors are foundational to the AFO prescription (“what is made”) and 
its outcomes (“how it is used”). This category included four subcategories: Knowledge, 
Parent/child perceptions, System, and Team. 
3.4.3.1 Knowledge  
 Participants discussed limitations regarding knowledge about AFOs. In general, PTs 
described few opportunities to learn about orthotics during professional post-secondary programs, 
and discussed the challenges of accessing relevant continuing education events. Continuing 
education opportunities described by orthotists seemed to focus on opportunities to learn about 
new products (often industry-sponsored). Participants discussed the need for more research 
evidence to help prioritize goals, and inform treatment decisions.  
3.4.3.2 Parent/child perceptions 
The parent and child’s perceptions about AFOs, were considered to impact acceptance of 
the AFO, compliance, and outcomes. As one PT described, "every family comes in with a certain 
coloured lens…in terms of how they view…disability, …their child, ….assistive devices. …It’s 
important for us as clinicians to be able to meet the needs of [all] families.”  
3.4.3.3 System 
Participants described factors related to the health care system that can affect service 
delivery. Considerations included funding for orthotic devices, and staffing levels and funding. 
Long wait times to see a physician in clinic (e.g., 3-6 months in one facility) as well as for 
orthotist services can be problematic for children. “For kids, not having a big wait time is really 
important, because if you cast and then you wait three months to get the splint, then it doesn’t 
necessarily fit the same way” (PT). Provincial funding also dictates the types of orthoses 
available, how often a child can receive a new AFO, and whether families must pay for a portion 
of the device. 
3.4.3.4 Team 
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Factors related to the health care providers and team may also strengthen or challenge 
outcomes. These included: proximity of team members, and communication with community 
professionals. Having the team in one building was considered beneficial for care providers, 
children, and families; one physician described it as “instrumental to…communication.” 
Collaboration and communication between the team and school/community practitioners also 
impact outcomes. One physician described a “major problem” that may occur when the child 
outgrows their current AFO and “the wrong AFO is…made without interim detailed 
assessment.”  
3.5 Discussion 
This qualitative study illustrates the experiences of Canadian clinicians with the process of 
prescribing and implementing AFO intervention for children with CP. Participants in these focus 
groups told us about how the prescription is determined (“what is made”), clinical follow-up 
(“how it is used”), and factors that either challenge or support prescription decisions and orthotic 
outcomes for this population. The theme of the prescription as a collaborative, iterative process 
was woven throughout the interviews. In contrast to the traditional definition of a prescription as 
a static medical directive, participants described the orthotic prescription as dynamic, and shaped 
by multiple inputs. They talked about how it often evolves iteratively, from the physician’s initial 
requisition to a design that is judged by the team and family to best meet the child’s goals.  
Participants described two factors as integral to the prescription’s evolution –
collaboration between PT and orthotist, and ongoing evaluation of the AFO’s effects. Both 
collaboration and evaluation appear to support clinical problem-solving. By conducting a joint 
assessment, and discussing the child’s needs and response to orthotic intervention, the AFO 
design may be determined or further refined. Although consistent implementation of both 
collaborative assessment (National Health Service Quality Improvement Scotland, 2009) and 
outcome measurement (Jette et al, 2009) have been recommended, there is no standard for 
integrating either process into a child’s orthotic care. According to our interviews, clinicians’ 
decisions about whether or not to collaborate, and the extent and timing of that collaboration 
seemed to depend on factors like clinician comfort with AFOs, proximity and accessibility of 
team members, and the perceived complexity of the child’s clinical presentation. The tendency to 
collaborate sporadically was also identified in a survey of clinicians in Scotland, who reported 
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PT-orthotist collaboration 50% of the time in their work with adults after a stroke (National 
Health Service Quality Improvement Scotland, 2009). 
With respect to outcomes evaluation, clinicians in this study reported limited use 
of standardized objective measures. Physical impairments (body structure and function) were 
commonly examined using non-standardized means (e.g., goniometry, inferences about muscle 
strength). Participants named a few measures of activity, and none of participation. However, 
they generally expressed an interest in using video gait observation to improve evaluation 
methods.  
Infrequent use of outcome measures is not specific to Canadian clinicians. Although the 
benefits of evaluating outcomes have been widely and repeatedly recognized, recent surveys in 
the USA and UK showed that fewer than half of PTs regularly use standardized outcomes 
(Burton, Tyson, & McGovern, 2012; Jette et al., 2009). Barriers and facilitators to use may 
include knowledge, education level, perceived value, practical considerations, and organizational 
support (Duncan & Murray, 2012). Specific barriers reported by participants in this study 
included time, space, digital storage, difficulty scheduling children for reassessment, and lack of 
access to objective tools (e.g., GAITRite walkways, 3D motion analysis).  
With a few exceptions, participants described an unsystematic, generalized approach to 
the evaluation that informs the prescription. And once the orthotic device has been fabricated, 
fewer evaluative measures are apparently used, with a greater reliance on subjective report to 
evaluate the child’s response. Visual gait observation was reportedly the most common way of 
evaluating the child’s walking pattern. It is used to both inform and evaluate the AFO 
prescription. Despite its wide popularity and clinical utility (Toro, Nester, & Farren, 2003), gait 
observation is subject to observer bias and error, and therefore its reliability and validity have 
been questioned (Kawamura et al., 2007; Toro, et al., 2003). Consistent with previous reports 
(Morris, Nedwick, & Johnson, 2002), participants described making prescription decisions based 
primarily on preference, subjective judgements, and local factors. 
The quality of clinical decision-making is thought to directly impact orthotic outcomes 
(Davids, et al., 2007). It has been suggested that effective decision-making for AFO prescription 
is multidimensional, and depends on the consideration of factors such as: 1) the physical 
assessment, 2) clear identification of the gait impairments and deficits that the AFO is intended 
to address, and 3) knowledge of the biomechanics of normal gait, the mechanics of gait 
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deviations, and the biomechanical capabilities of different types of orthoses (Davids et al., 2007). 
Prescription is also more likely to be successful when each team member has contributed to, and 
reached agreement in, the decision-making process; so collaboration and integration of the goals 
of the physician, therapist, orthotist, child, and family are imperative (Davids, et al., 2007; 
Morris et al., 2011).  
In line with these recommendations, our results suggest that clinicians endeavour to base 
their prescriptions on assessment findings and gait impairments, and to collaborate within the 
constraints of the system. However, it has been suggested that clinical AFO prescription is often 
based on “inadequate biomechanical knowledge” (National Health Service Quality Improvement 
Scotland, 2009,  p.18). While an examination of clinical reasoning was beyond the scope of the 
study, knowledge did emerge as a factor that challenged prescription practises. As such, clinical 
outcomes are likely to benefit from ongoing research to understand the biomechanical effects of 
specific AFO design features on gait. This knowledge may inform the development of clinical 
guidelines that enable a better match between the prescription and the orthotic goal.  
It should be noted that both purposive sampling and focus group methodology carry a 
risk of bias. While we did invite physicians of other specialties to participate, all four who 
participated were physiatrists. As well, our sample did not include privately-funded PTs or 
orthotists, or those working in the community. It is possible that these groups may have reported 
different experiences. In addition, the multidisciplinary group format may have influenced what 
participants said. Interactions between disciplines were collegial and agreeable, however, 
interviewing the disciplines together may have biased what was said about collaboration or team 
functioning. Individual interviews may have highlighted other aspects of interdisciplinary 
communication or discrepant viewpoints within teams. 
3.5.1 Recommendations for Clinical Practice and Future Research 
Based on our analysis of this data and background literature, two main priorities for 
clinical practice emerged: 1) the development of evidence-informed best practice guidelines, and 
2) a stronger focus on objectively evaluating each child’s response to the orthosis. Both 
initiatives could help clinicians make better prescription decisions that address the goals of 
intervention.  
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Table 3.2. Recommendations for clinical practice and for future research 
Practice recommendations  
1. Initial prescription: 
• Clearly state team’s and family’s goals for AFO 
• Use standardized orthotic referral form completed by orthotist, PT, and/or doctor  
• PT and orthotist conduct assessment jointly, AFO design (prescription) finalized 
by orthotist  
• Individualize prescription based on standardized objective assessment 
2. Measurement: 
• Use objective evaluation measures to  
• Support biomechanical basis for individualized prescription  
• Evaluate the effect of AFO once received 
• Consider implementing a standardized gait observation checklist and videotaped 
visual gait observation to inform prescription and evaluate effectiveness 
• Choose measures directly related to family’s goals and consider all ICF levels 
3. Collaboration:  
• Implement consistent inter-disciplinary communication and collaboration 
• Access continuing education opportunities in the areas of orthotics and 
biomechanics 
Research recommendations 
1. Develop valid and reliable measures of gait quality and participation specific to 
orthotic evaluation. 
2. Examine parent and child perceptions of AFO intervention in order to understand 
what is meaningful to clients, and identify the most effective targets for evaluation. 
3. Examine how different aspects of the AFO prescription can be altered to optimize a 
child’s gait biomechanics.  
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The National Health Service Quality Improvement Scotland’s best practice guidelines 
(National Health Service Quality Improvement Scotland, 2009) summarize key 
recommendations for AFO management of individuals with stroke, borrowing from the CP 
literature in some cases. This document could be used as a model for developing and providing 
orthotic service for clinicians working with children who have CP. 
Recommendations for practice and future research, based on our findings, are 
summarized in Table 3.2. Although many of these recommendations are highlighted in the 
pediatric and adult literature, we recognize the challenges of implementation in the present 
clinical context. Canada’s geographic size and population distribution require some facilities to 
serve communities located several hundred kilometers away. The proximity of orthotic and PT 
facilities is sometimes less than ideal, and resources are limited. Enhanced collaborative 
practises, for instance, require appropriate infrastructure and organizational support (e.g., 
adequate time and staffing levels). Some centres described the impact of orthotist understaffing 
in relation to the demand for services. However, with only two orthotic/prosthetic schools in 
Canada, the annual number of graduates may not meet the demand. And finally, as Duncan and 
Murray (2012) identified, barriers at the organizational, team, and individual levels must be 
addressed if the use of outcome measures in practice is ever going to increase. Future research 
has the potential to improve the meaningfulness of orthotic interventions, give clinicians tools to 
measure outcomes, and facilitate an understanding of the effects of AFO prescriptions so that 
prescription becomes more effective and individualized according to the child’s needs and goals. 
We hope that a better understanding of the factors that influence AFO prescription will 
benefit clinicians and represent a first step towards developing guidelines to improve AFO 
prescription for children with CP. The information shared by clinicians in these interviews, along 
with the current literature, support the recommendations we have made. A greater focus on 
collaboration and objective outcome evaluation (from organization to individual) has the 
potential to improve orthotic outcomes for children with CP. 
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CHAPTER 4: PHYSICAL THERAPISTS’ USE OF EVALUATION MEASURES TO INFORM 
THE PRESCRIPTION OF ANKLE-FOOT ORTHOSES FOR CHILDREN WITH CEREBRAL 
PALSY 
Manuscript re-published with permission, and edited from its original format. Original citation: 
Kane, KJ, Lanovaz, JL, Musselman, KE. (2018). Physical therapists' use of evaluation measures 
to inform the prescription of ankle-foot orthoses for children with cerebral palsy, Physical & 
Occupational Therapy in Pediatrics.  
4.1 Abstract 
Aims: To examine how physical therapists (PTs) use evaluation measures to guide prescription 
and re-assessment of ankle-foot orthoses (AFOs) for children with CP. Methods: PTs in Canada 
who work with children with CP were invited to complete an online survey. Survey questions 
examined PT evaluation and interpretation of findings at initial AFO prescription and re-
assessment. The researchers analyzed closed-ended responses using descriptive statistics and 
conducted a conventional content analysis to examine responses to open-ended questions. 
Results: Sixty responses from ten provinces were analyzed. Three themes emerged from the 
open-ended responses, which were supported by closed-ended responses. 1) Focus on 
impairment-level measures. Although evaluation primarily involved observational, non-
standardized measures of impairments and gait pattern, most respondents also considered 
participation-level constructs. 2) Lack of confidence/knowledge. Respondents reported a 
moderate level of confidence concerning decision-making about AFO type and characteristics. 3) 
Inconsistent practices between therapists, possibly reflecting the paucity of available evidence or 
individualization of the prescription. Conclusions: Non-standardized, observational assessment 
methods, and impairment-level constructs appear to guide AFO prescription decisions. 
Integrating current knowledge into practice, developing best practice guidelines, and developing 
standardized tools to assess the effects of AFOs on participation may promote confidence, 
consistency, and improved outcomes.  
KEYWORDS: cerebral palsy, ankle-foot orthoses, evaluation, survey  
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4.2 Introduction 
When ankle-foot orthoses (AFOs) are prescribed to improve function, gait quality, alignment, 
and/or prevent contractures and deformity for children with cerebral palsy (CP) (Morris et al., 
2011; Novachek et al., 2009), physical therapists (PTs) work with the physician, orthotist, and 
family to determine the optimal prescription and provide therapeutic follow-up. (Davids et al., 
2007; Kane, Manns, Lanovaz, & Musselman, 2018; Uustal, 2008). Prescription decisions to 
which PTs contribute include the AFO type, casting position of the foot and ankle, and other 
design features like trimlines.  
Presently, little guidance exists to help clinicians determine the optimal AFO prescription for 
each child (Bowers & Ross, 2009; Kane et al., 2018; Morris, 2002). The prescription should be 
individualized, because each child has unique characteristics across the domains of the 
International Classification of Functioning, Disability and Health (ICF) framework (World 
Health Organization, 2016a) including body structures and functions (e.g. spasticity), activity 
(e.g., gait pattern), and participation (e.g., attending school) (Schiariti & Masse, 2015; World 
Health Organization, 2016b). In the ideal prescription process, orthotic goals are identified, and 
progress is objectively evaluated (Davids et al., 2007; Ries et al., 2015). A growing body of 
evidence supports individualized biomechanical optimization – including designing, aligning, 
and tuning the AFO-footwear combination (AFO-FC) – to maximize the effectiveness of 
intervention (Bowers & Ross, 2009; Butler et al., 2007; Eddison & Chockalingam, 2013; 
Jagadamma et al., 2014; National Health Service Quality Improvement Scotland, 2009; Owen, 
2010). The type of AFO (e.g., solid, hinged, ground reaction) should be selected and designed to 
match the individual’s neurological and biomechanical impairments (Meadows et al., 2008; 
National Health Service Quality Improvement Scotland, 2009; Owen, 2010). When a solid AFO 
is prescribed, it is recommended that the AFO-FC is tuned to optimize the child’s gait pattern; 
this involves adjusting the shank to vertical angle by adding thin wedges under the heel, thereby 
altering the location of the ground reaction force relative to the knee and hip joints (Meadows, 
2014). Although the angle of the ankle in the AFO (AA-AFO) has traditionally been set at 90˚ 
with the aim of maintaining ankle range of motion (ROM), a plantar flexed AA-AFO has been 
posited to accommodate gastrocnemius stiffness and hypertonicity, if present (Meadows et al., 
2008; Owen, 2005; Ridgewell et al., 2010). However, the extent to which current practices 
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incorporate the available literature is unclear, and present evidence suggests that clinically-
prescribed AFOs may have limited, or even detrimental, effects (Bjornson et al., 2016; Ries et 
al., 2014).  
As a first step toward improving the efficacy of AFO prescription practices, we conducted 
focus group interviews with PTs, orthotists, and physicians to gain a better understanding of 
clinicians’ experiences with AFO prescription for children with CP in Canada (Kane et al., 
2018). Participants identified PT evaluation as a key aspect of the prescription process. 
Evaluation using standardized outcomes is an accepted component of good practice, helping to 
enhance communication with clients, evaluate and guide intervention, and improve service 
provision (Jette et al., 2009; King et al., 2011). While participants in our focus groups 
endeavored to base prescriptions on assessment findings, they generally described a subjective 
and unsystematic approach to assessment, decision-making, and follow-up (Kane et al., 2018). 
Although PTs evaluate body function-level impairments (e.g. ROM, strength) that are 
thought to affect mobility and function, the specific aspects of assessment that inform 
individualized prescription – and how these data influence clinical decisions – have not been 
explored. Therefore, we conducted a survey, based on the results of our focus group interviews, 
to identify: 1) what PTs evaluate when AFOs are prescribed for children with CP and after the 
orthosis is received; 2) what assessment measures are used; and 3) how those measures inform 
prescription. We hypothesized that: 1) PTs do not consistently utilize objective measures to 
evaluate an AFO’s effects, but instead rely on non-standardized measures and observation; and 
2) perspectives and practices vary regarding indications for different types of AFOs, use of 
plantar flexed AA-AFOs, and interpretation of findings to determine the prescription and follow-
up adjustments.    
4.3 Methods 
4.3.1 Participants 
Surveys were completed by 60 PTs who had a median of 15 years of PT experience 
(interquartile range=8-21 years) and a median of 10 years in paediatrics (interquartile range=4-
17 years). At least one response was received from each province, and half were from Ontario 
(28%) or British Columbia (23%). Most worked exclusively in publicly-funded settings (89%), 
while 11% worked additionally or exclusively in privately-funded settings. Half (52%) worked 
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with orthotists located on-site. Most respondents (53%) treated one to four children with CP per 
week, while 40% treated one to three per month, and 7% saw one per day.   
Participants were recruited via snowball sampling. Study information, including the survey 
link, was sent by email to 35 PTs at 28 facilities that treat children, in all ten Canadian provinces. 
No eligible contacts were identified in the territories. The invitation included a request to 
forward the link to other eligible PTs, to maximize its distribution. The survey was also 
advertised in an email newsletter by the Canadian Physiotherapy Association’s Pediatrics 
Division, and on social media (e.g., Facebook). Participants were included if they were licensed 
PTs in Canada who had been involved in AFO prescription for at least one child with CP in the 
past two months. In total, sixty-six completed surveys were received (online supplementary 
appendix 1). Of these, six did not meet inclusion criteria and were excluded. Therefore, data 
from 60 complete responses were analyzed. The study was approved by the University of 
Saskatchewan’s research ethics board. 
4.3.2 Survey Instrument 
The researchers developed the survey based on the study objectives, and informed by the 
focus group interviews (Kane et al., 2018). It was translated into French by a bilingual PT and 
the content and intent of the questions were discussed to facilitate accurate translation. The 
content validity of the instrument was then evaluated by five PTs in four provinces, all of whom 
were experienced with AFO intervention for children with CP (Aday & Cornelius, 2006). Four 
examined the English version and one evaluated the French version. These content experts had 
18 to 40 years of clinical experience, in addition to teaching (PT entry-to-practice or continuing 
education) and/or clinical research. Content experts completed the survey and were asked for 
feedback about whether the questions were clearly worded and addressed the stated objectives, 
and to identify any gaps or suggestions for improvement. The survey was subsequently adjusted 
based on this feedback, which was provided to one of the researchers (KJK) during a 15- to 30-
minute individual telephone interview for four of the experts, and via email for the fifth expert.  
The final version of the survey consisted of 28 questions (six open-ended, 22 closed-ended, 
which are summarized in Table 4.1). It was deployed online (SurveyMonkey) in English and 
French. Close-ended questions addressed: 1) demographics; 2) evaluation measures used to 
inform initial prescription and re-assessment; and 3) recommendations for AFO design and 
adjustments post-fitting. Open-ended questions asked about the clinical indications for different 
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types of AFOs, the most important information examined initially and at re-assessment, opinions 
about the benefits or harms of a plantar flexed AA-AFO, and the types of adjustments 
recommended at re-assessment. For example, respondents were asked to base their responses 
about initial assessment on the following scenario: “An 8-year-old ambulatory child with CP 
comes to you for an assessment. AFOs have been suggested for the child. The physician wants 
your recommendation about the AFO type (solid, hinged, etc.) and characteristics (stiffness, 
trimlines, ankle angle, etc.) before writing the prescription.” 
4.3.3 Data Analysis 
Survey responses were exported into an Excel file for data cleaning and analysis. 
Incomplete responses were removed, and French responses were translated into English. 
Descriptive statistics were calculated to summarize closed-ended responses. The assumption of 
normality was tested using a Kolmogorov-Smirnov test. To examine the strength of the 
association between confidence in AFO prescription and years of experience in both pediatric 
and PT practice, Spearman’s rank correlation coefficient was calculated using SPSS (Version 
24). Two researchers (KJK and KEM) independently performed a conventional content analysis 
(Hsieh & Shannon, 2005) on the open-ended responses. Responses were reread several times to 
identify important concepts and impressions about the content’s meaning. Key words and 
phrases were inductively grouped into categories, and preliminary themes were established 
through discussion. A third researcher (JL) then independently reviewed the open-ended 
responses and preliminary themes. The three researchers discussed and adjusted the preliminary 
themes to form the final themes.  
4.4 Results 
All 60 respondents were involved with initial prescription and re-assessment once the child 
received the AFO, and most also agreed about the value of re-assessment. On a 100-point scale 
(0=not important; 100= extremely important), respondents rated the median importance of re-
assessment as 95.5 (interquartile range= 84.75-100). Seventy percent reported that they re-
assessed 95-100% of children who received AFOs. Responses indicated that orthotists and PTs 
often assess children
 39 
 
Table 4.1. Summary of survey questions. Open ended questions are denoted by (*). All other questions were closed-ended, and used a 
variety of response formats (e.g., 5-point Likert scales, slider scales, free text boxes, multiple choice).  
Section of survey Summary of questions 
1. Demographics 1.    In the past 2 months, how often have you been involved in AFO prescription for a child with CP, or made decisions about the 
AFOs of a child with CP? (This may include checking or re-assessing a child's AFOs as part of a treatment session or 
contributing to decisions about new AFOs.) 
2. In which province do you work? 
3. How many years have you worked as a physiotherapist? 
4. How many years have you worked in paediatrics? 
5. Please describe your main work setting  
6. Where are the orthotists that you work with located?  
7. How confident are you in your ability to recommend the correct AFO type (solid, hinged, etc.) and characteristics 
(stiffness, trimlines, ankle angle, etc.) for children with CP? 
2. Recommendations 
about AFO prescription 
The next questions relate to the following scenario:  
An 8-year-old ambulatory child with CP comes to you for an assessment. AFOs have been suggested for the child. The physician 
wants your recommendation about the AFO type (solid, hinged, etc.) and characteristics (stiffness, trimlines, ankle angle, etc.) 
before writing the prescription. 
8. Please select the items that you think would likely be most helpful in making this decision. 
9. How do you measure each item? If you use any specific tools, please list them (e.g., videorecording, goniometer, names of 
standardized outcome measures or clinical tests). 
10. Of the information that you consider when recommending an AFO for a child, which ones usually influence your decision 
the most? Please list the three most important things that you assess, in order of their importance. 
11.  How do you evaluate the child's gait, to make a decision about the type of AFO you are recommending? 
12. Please describe the most important examination findings that would lead you to suggest each of the following AFO types: 
Solid AFO, Hinged AFO, Posterior leaf spring/other semi-flexible AFO, Ground Reaction AFO, Energy Storage and 
Return AFO, Carbon Fiber AFO.* 
13. How do you decide whether a hinged AFO or a solid AFO is more appropriate for a child? If there are certain assessment 
findings that help you to decide between these 2 types of AFO, please describe them as specifically as you can.*  
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3. Casting positions for 
the foot and ankle 
A doctor prescribes a new AFO for a child on your caseload, and a casting appointment is scheduled with an orthotist. The 
following questions relate to the recommendations you make about the position of the child's foot and ankle in a new AFO. 
14. For the children you see, how often do you provide recommendations to the orthotist about the position of the foot and ankle in 
the cast? 
15. For the children you see, how often are AFOs fabricated with the ankle positioned at a plantarflexed angle? 
16. What examination findings would cause you to recommend positioning the ankle at a plantar flexed angle in an AFO?* 
17. How harmful or beneficial do you believe it is to position an ankle in plantarflexion in an AFO? 
18. Why do you think it may be harmful or beneficial to position an ankle in plantar flexion?* 
4. Follow-up evaluation 
for a new AFO 
The next questions are about PT follow-up evaluation for an ambulatory child who has received a new AFO.  
19. Please select the items you would likely assess, to evaluate the effects of the new AFO. 
20. How would you measure each item during your re-assessment? If you use any specific tools, please list them (e.g., 
videorecording, goniometer, names of standardized outcome measures or clinical tests). 
21. Please list the three most important things that you assess to evaluate the effect of an AFO, in order of their importance. 
22. Of the children you see with AFOs, approximately how many do you re-evaluate once they have a new AFO, to check how 
well the AFO is working for the child? 
23. How important do you think it is to complete a PT evaluation after a child gets a new AFO? 
5. AFO-footwear 
combination tuning and 
adjustments 
The following questions are about adjustments to the AFO and footwear that you might make after a child receives a new AFO. 
24. When a child gets a new AFO, have you ever made or recommended adjustments (e.g., to the orthotist) to optimize how the 
child walks in it? 
25. Please describe some examples of adjustments that you usually make or recommend for the AFO and/or footwear, in order to 
improve the way the child walks.* 
26. How often do you make or recommend adjustments or modifications to the AFO or footwear? 
27. How do you evaluate the AFO and footwear to make this decision? 
28. Is there anything you would like to suggest, in order to improve assessment and prescription/recommendation of AFOs?*  
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together; more than half of the time, 60% reported doing joint initial assessments, and 53% did 
joint re-assessments. In comparison, 28% and 26% of PTs performed initial assessments and re-
assessments, respectively, together with another PT more than half the time. Physicians were less 
often involved, with 35% and 18% of PTs performing initial assessments and re-assessments, 
respectively, with a physician more than half the time.  
Only 32% of respondents reported making recommendations about the casting position of the 
foot and ankle for more than half of children. Even if they did not make recommendations, most 
believed that positioning the ankle in some plantar flexion was beneficial when indicated; on a 
100-point scale (0=extremely harmful; 100=extremely beneficial under the right circumstances), 
the median rating was 72 (interquartile range=52-91.25). Approximately 77% of respondents 
recommended a plantar flexed AA-AFO at times, typically for fewer than half of children. 
Twenty-two percent never used a plantarflexed AA-AFO. 
Most respondents described making several types of recommendations once a child receives 
an orthosis. More than 2/3 of these involved facilitating adjustments by the orthotist to relieve 
pressure areas and improve the fit and comfort of the AFO via padding, trimming, and flaring the 
plastic. Adjustments to straps and footwear recommendations (type, size, optimizing the fit of the 
footwear) were mentioned less often (50%). Fewer recommendations pertained to the goal of 
optimizing gait mechanics. For example, less than 30% mentioned wedges (without specifying 
the purpose), and only 10% specifically mentioned tuning. The least prevalent recommendations 
(about 5%-20%) aimed to improve gait by various other means. These included adding joints to 
solid AFOs, adjusting the AA-AFO or the amount of motion the AFO allowed, adding shoe 
raises to equalize leg lengths, posting the AFO to alter alignment, and adjusting the AFO’s 
stiffness by altering its trimlines.  
4.4.1 Themes  
Three themes for evaluation practices in AFO prescription were identified based on 
responses to the open-ended questions: 1) focus on impairment-level measures; 2) lack of 
confidence/knowledge about types of AFOs and casting position of the ankle; and 3) inconsistent 
practices between therapists. 
4.4.1.1 Focus on impairment-level measures 
Individualized recommendations for AFO type and AA-AFO were primarily guided by 
impairment-level assessment measures and findings. Respondents described how the AFO type 
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was frequently determined by ankle dorsiflexion ROM and plantar flexor tone (including 
R1/“first catch”, R2/“muscle length at rest”, and the difference between the two as an indication 
of dynamic tone or contracture; Boyd & Graham, 1999), strength, and alignment. Activity-level 
considerations were function and gait pattern. One respondent said a hinge is “require[d]… for 
function (stairs, sit-to-stand, floor-to-stand, squatting).”  Crouch gait was described as an 
indication for solid AFOs, and being ambulatory was generally an indication for hinged AFOs. 
Similarly, two impairment-level factors—dorsiflexion ROM, including the presence of 
contracture, and plantar flexor tone (specifically, R1 and the difference between R1 and R2)—
were described as primary influences on the choice of AA-AFO. Many PTs thought a plantar 
flexed AA-AFO could allow a child with limited dorsiflexion ROM to tolerate an AFO or gain 
ankle ROM; however, they also expressed concern that a plantar flexed AA-AFO could cause 
contracture if the child had more dorsiflexion ROM available. Therefore, many recommended 
changing the AA-AFO as ROM improved. At the activity level, a plantarflexed AA-AFO “may 
be necessary to get best gait pattern [if there is a contracture].”  
The predominant influence of impairment-level constructs on the initial prescription was 
corroborated by the closed-ended responses. Figure 4.1 illustrates the breadth of variables 
evaluated (e.g., ROM, gait pattern), and the frequency with which each is examined at initial 
assessment and re-assessment. At initial assessment, gait pattern, ROM, and muscle tone were 
most frequently evaluated (impairment- and activity-level constructs); however, participation-
level constructs were evaluated by 68% of respondents. On re-assessment, it was most common 
to examine gait pattern, parent/child satisfaction, and participation in school, social, and 
recreational activities (activity- and participation-level constructs). Participants ranked ROM as 
the most important construct to evaluate at initial assessment, followed by gait pattern, and 
muscle tone (Figure 4.2). At re-assessment, gait pattern, pain/comfort/fit, and gross motor 
function were reported as the most important variables to evaluate.  
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Figure 4.1. Information that PTs evaluate at initial assessment (when making recommendations 
about the AFO prescription) and re-assessment (after the child has the AFO).  
*Shank to vertical angle 
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Figure 4.2. Most important information to consider at initial assessment and re-assessment (by 
% of respondents).  
*Shank to vertical angle  
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4.4.1.2 Lack of confidence/knowledge about types of AFOs, and casting position of the 
ankle  
Participants reported a wide range of confidence levels for making decisions about AFO type 
and characteristics. On a scale of 0-100 (0=not confident at all; 100=extremely confident), the 
median rating was 57.5 (interquartile range=37-69). Some also described a lack of 
knowledge/confidence in their open-ended responses (e.g., “I am still guessing, defer to 
orthotist.”) Confidence rating was moderately correlated with years of pediatric PT experience 
(=0.52; p<0.001) but only weakly correlated with overall PT experience (=0.38; p=0.003). 
When asked to describe clinical indications for six different types of AFOs– solid, hinged, 
ground reaction, posterior leaf spring, energy storage and return, and carbon fiber– most were 
unfamiliar with the latter four types. Those who used ground reaction AFOs consistently cited 
crouch gait as the primary indication. Those who used posterior leaf spring AFOs typically 
reported using them for children who had drop foot without excessive gastrocnemius 
hypertonicity. The few who used carbon fiber AFOs suggested that they were useful for active 
children with minimal impairment (e.g., foot drop, plantar flexor weakness, “lighter weight 
support in adolescent population”, or at least neutral dorsiflexion ROM).  
Respondents appeared most confident about indications for solid and hinged AFOs, although 
responses were inconsistent (as described in theme 3, below). Many participants appeared to 
view solid and hinged AFOs as having opposite indications. Overall, solid AFOs were reportedly 
used for less ambulatory children with poor ROM, significant spasticity, and poor mid-foot 
integrity. In contrast, hinged AFOs were recommended for more ambulatory children with higher 
functional abilities, “adequate ROM”, less spasticity, and good mid-foot integrity. Some 
respondents also described uncertainty about why a plantar flexed AA-AFO may be harmful or 
beneficial. One PT stated: “Based on my experience and training of 30 years ago, this practice 
would not be recommended. However, you asking this question leads me to believe there may be 
more recent thinking [regarding the] use of [a plantar flexed AA-AFO].”  
4.4.1.3 Inconsistent practices between therapists  
Responses reflected inconsistency across PTs regarding the rationale for determining AFO 
type and AA-AFO. Some only used hinged AFOs for children with “normal shank kinematics” 
and minimal impairments: “I usually default to solid unless there is optimal range, strength, and 
no concern regarding bony alignment.” Others “preferred hinged AFOs for all ambulatory 
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children. One PT wrote: “First choice is hinged as it provides a more natural gait pattern, but 
sometimes this cannot be used if the client falls into crouch or lacks ROM.” These respondents 
tended to perceive that solid AFOs are “most appropriate as a resting…splint” and “negatively 
impact gait pattern in an ambulatory client”, while hinged AFOs promote ankle motion and 
function. 
Some respondents indicated that a plantar flexed AA-AFO may “decrease stability in 
standing/walking,” and impair function or gait pattern (e.g., “not functional”; “could 
promote…hyperextension of knee in gait and/or toe walking.”), while others described benefits 
(e.g., “can allow for heel strike”; “allow ‘normal’ shank/thigh kinematic and knee/hip range 
throughout gait.”) One respondent indicated: “It would be harmful to not have the ankle in 
plantar flexion if the client has insufficient range with knee extended in the standing position. 
This could lead to pain and…worsening of range due to…compensations.” 
Most responses illustrated a lack of detail surrounding decision-making. When asked how 
they determined the AFO type, many respondents merely named the constructs that they 
measured (e.g., “[the choice of AFO] depends on knee control, amount of tone and functional 
skills”). The few responses that explicitly described how they interpreted their measurements 
lacked consistency. For example, ROM was the most common factor guiding both AFO type and 
AA-AFO; yet there was little agreement about how much ROM is needed to warrant either 
decision. Opinions about ROM indications for a hinged AFO included: “adequate range”, 
“enough range past neutral to tolerate hinged AFO”, “neutral,” “>5 degrees,” or “>10 degrees”, 
and “some active dorsiflexion”. Some stated that a contracture and “R2 <90 degrees” warranted 
a plantar flexed AA-AFO, while others focused on dynamic limitations (e.g., “I prefer to have 
the child cast close to their R1 angle. If the R1 is in a plantar flexed position I will request the 
AFO be in plantar flexion.”) Others were less specific about rationale (e.g., “not tolerating 
neutral dorsiflexion”) or described the individualized nature of decisions: “Depending on the 
tightness and tone of the plantar flexors it is either harmful or beneficial to position the ankle in 
plantar flexion. It’s a big grey area and each child is different.”  
There was considerable variety in the evaluation methods that PTs selected to inform AFO 
prescription and re-assessment (Table 4.2). More than one evaluation method was reported for 
most variables, with a combination of non-standardized/observational methods and 
standardized/objective measures reported. For example, gait was evaluated more often by 
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observation than by more structured tools (e.g., video, standardized checklists, instrumented 
measures; Figure 4.3); however, ROM, was primarily evaluated with objective tools, such as a 
goniometer. More objective gait measures were used more frequently at initial prescription than 
at re-assessment.  
4.5 Discussion 
This survey study examined the way PTs in Canada use evaluation measures to inform 
AFO prescription for children with CP. Responses suggest that, in AFO prescription: 1) PTs base 
decisions primarily on impairment-level findings; however, the majority of PTs also consider 
activity- and participation-level constructs and use a combination of standardized and non-
standardized evaluation measures; 2) there is a lack of confidence/knowledge about decision-
making; and 3) there is inconsistency across PTs in evaluation practices and interpretation of 
findings. These results partially support our hypotheses and provide new insights about PT 
evaluation practices for AFO prescription. In Table 4.3 we detail recommendations for clinical 
practice and future research and discuss them in the following paragraphs.   
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Table 4.2. Assessment tools and methods used by PTs to make AFO decisions at initial assessment and re-assessment, in order of frequency of use 
Constructs being assessed* Initial assessment (Most common to least common) Re- assessment (Most common to least common) 
Range of motion  1. Goniometer;  
2. Special tests (e.g., Thomas test; Duncan Ely test) 
1. Goniometer 
Muscle tone 1. MASa, MTSb (specifically R1/R2), informal assessment 1. MAS, MTS, or informal assessment 
R1 (plantarflexors)  1. Goniometer 1. Goniometer 
Bony alignment 1. Observation, palpation, goniometer 
2. Thigh-foot angle, foot progression angle, x-ray, caliper, angle finder, bi-
malleolar axis, foot axis, Ryder's test 
1. Observation 
2. Goniometer/ clinical measurements 
3. Photos or video 
Muscle strength 1. Manual muscle testing 
2. Observe functional skills, squat, calf raises 
1. Manual muscle testing 
Leg length 1. Tape measure 
2. Visual estimate, Galeazzi test, standing (block test), X-ray 
1. Tape measure 
2. Standing (block test) 
Pain 1. Pain scale (e.g., VASc, NPRSd, faces scale), subjective report 1. Pain scale (VAS, NPRS) or subjective report 
Selective voluntary control  1. Observation of functional skills  
2. SCALEe, confusion test, isolation of movement 
1. Observation 
Shank to vertical angle and shank 
kinematics during gait 
1. Observation or video 
2. Goniometer; gait lab  
1. Observation or video 
2. Goniometer; gait lab  
Gait pattern (general appearance, 
e.g., crouch, scissoring) 
1. Observation 
2. Video recording 
3. OGSf; EVGSg (with video); 3D motion analysis 
1. Observation 
2. Video recording 
3. OGS; EVGS (with video); 3D motion analysis  
Spatio-temporal variables (e.g., 
step length, velocity) 
1. Observation, video 
2. Gait lab, GAITRite, video (measured background), tape measure 
1. Observation, video  
2. Gait lab, GAITRite, 6-minute or timed walk test 
Gross motor skill 1. Observation, standardized test (GMFMh, BOT-2i, MABC-2j, PDMS-2k, 
TGMD-2l), or non-standardized developmental checklist  
1. Observation, standardized test (e.g., GMFM, PDMS-2), 
or non-standardized checklist 
Goals 1. Informal discussion with parent/child   
2. SMARTm goals, GASn, COPMo  
1. Informal discussion with parent/child   
2. Repeat GAS or COPM 
Parent/child preference (initial) or 
satisfaction (re-assessment) 
1. Informal discussion child/parents 1. Informal discussion with child/parents 
Participation in school/ 
social/recreational activities 
1. Informal discussion with child/parents 1. Informal discussion with child/parents, +/-teacher 
2. COPM, observation, review goals 
3. Pediatric Community Participation Questionnaire 
Other  1. Consult with or defer to other professionals 1. Skin integrity (redness/pressure), observation 
*Identified during focus group interviews; aModified Ashworth Scale; bModified Tardieu Scale; cVisual Analog Scale; dNumerical Pain Rating Scale; eSelective Control Assessment of the Lower 
Extremities; fObservational Gait Scale; gEdinburgh Visual Gait Score; hGross Motor Function Measure; iBruininks-Oseretsky Test of Motor Proficiency, 2nd ed;  jMovement Assessment Battery for 
Children; PDMS-2: kPeabody Developmental Motor Scales; TGMD-2: lTest of Gross Motor Development; mSpecific, Measurable, Agreed upon, Realistic, Time-based; nGoal Attainment Scaling; 
oCanadian Occupational Performance Measure
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4.5.1 Measure Participation-Level Outcomes 
Although impairment-level measures seemed to influence decisions (especially at initial 
prescription), current rehabilitation paradigms for children with CP consider outcomes at all ICF 
levels (Anaby et al., 2017; Law & Darrah, 2014; Novak, 2012). In particular, activity- and 
participation-level goals are among the most valuable to the child and family (Naslund et al., 
2003; Schiariti et al., 2014). Moreover, pediatric rehabilitation is shifting toward activity- and 
participation-oriented paradigms because impairment-based approaches (e.g., “fixing the child”) 
have not been demonstrated to be effective (Law & Darrah, 2014). Participants reported 
assessing two activity-level constructs – gait pattern and gross motor function; however, this was 
typically done via informal observation, which is likely to be less objective (see section 2.5.2).  
Most PTs considered participation when making decisions (i.e., 68% at initial assessment and 
83% at re-assessment); yet, fewer than 30% ranked it as one of the three most important 
constructs to measure. One possible explanation for this finding is that the choice of evaluation 
measures should be consistent with the purpose and the expected outcome of the AFO; and 
clinicians primarily prescribe AFOs to impact impairments and gait pattern, without expecting 
participation-level effects (Kane et al., 2018). Further, while only two respondents named 
standardized participation-level measures, six used goal setting tools, which may also reflect 
activity- and participation-level goals. Goal setting tools may be preferable to participation-
specific tools in some circumstances, such as where AFOs are prescribed to address alignment or 
deformity, rather than participation-level effects.  
It is also worth noting that the information provided by assessment of certain constructs may 
be more relevant at either the initial prescription or at re-assessment; this may explain why some 
constructs were evaluated more often at one time-point compared to the other. For example, 
ROM, strength, tone, R1, alignment, leg length, and selective voluntary control were more often 
considered at initial prescription. This information may be more relevant to decisions about the 
type of AFO and prescription details. Conversely, re-assessment may be a more relevant time to 
assess participation, satisfaction, pain, and spatiotemporal variables, as this dispensing visit 
serves as a baseline for evaluating the effect of the new AFO on these important constructs. 
4.5.2 Increase use of standardized measures 
Overall, our results indicate that PTs use few objective, standardized measures for initial 
AFO prescription; and at re-assessment, they may be more reliant on subjective report. Despite 
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challenges associated with outcome measurement in rehabilitation (Jette et al., 2009; King, 
Wright, & Russell, 2011), more consistent measurement at baseline and follow-up may present 
an effective strategy to improve orthotic outcomes in this population, as well as clinician 
confidence for prescription decision-making. Without quantification, clinicians are unlikely to 
obtain the objective information necessary to specifically identify and communicate about the 
child’s gait impairments, quantify progress, or optimize the orthosis. They may also miss 
opportunities to improve care by engaging families and promoting shared decision-making based 
on the platform for discussion that measurement provides (King et al., 2011). While measures do 
exist for this population at all levels of the ICF (O’Neil et al., 2006), there is a need for reliable 
outcome measures with high clinical utility, specifically for orthotic evaluation (Table 4.3).  
4.5.3 Develop evidence-based clinical guidelines 
Although we did not examine the relationship, it is possible that a PT’s knowledge or beliefs 
about AFOs (theme 2) may contribute to inconsistent practices and interpretation of assessment 
findings between therapists (theme 3). The qualitative data illustrate variability in both decision-
making and knowledge/beliefs about AFOs. A notable example was the belief that hinged AFOs 
were appropriate for all ambulatory children. In contrast, several authors have asserted that the 
use of a hinged AFO for children with stiff or short gastrocnemius (e.g., unable to achieve 10˚ of 
dorsiflexion with the knee extended and arch maintained) may result in dorsiflexion at the 
midfoot joints, contributing to mid-foot break and potential future pain and immobility (Bowers 
& Ross, 2009; Karas, 2002; McGovern & Rahlin, 2016; Meadows et al., 2008; Owen, 2015).  
Solid AFOs have been advocated for children with abnormal shank kinematics (i.e., atypical 
motion of the shank segment in the sagittal plane during gait; Meadows et al., 2008; Owen, 
2010), yet few respondents based their decisions on this variable. It is also possible that some of 
the variability present in the responses reflects individualization of the prescription based on the 
child’s needs. As well, clinician confidence and consistency in orthotic decision- making is 
likely impacted by the paucity of consistent evidence about orthotic options and
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Table 4.3. Recommendations for clinical practice and future research based on issues identified in the results 
Issue Recommendations for clinical practice Recommendations for future research 
1. Specific and objective 
participation measures are not 
consistently used at initial 
prescription and re-assessment 
1. Discuss participation goals with parents/child  
2. Include standardized measures at the 
participation level, such as the bCOPM, 
cCAPE, or dPCPS 
1. Determine whether adequate measure of participation exists 
for AFO evaluation, and if not then develop one 
2. Examine effects of AFOs on participation 
2. Infrequent use of 
standardized measures to 
evaluate efficacy of AFO 
prescription  
1. Clinician education regarding suitable 
standardized outcome measures at each ICF 
level (e.g., aEVGS, bCOPM, cCAPE, dPCPS) 
2. Document goals and a plan for objective 
evaluation at initial assessment; objectively 
document outcomes after child receives AFO 
3. Wearable sensors may enhance the objectivity 
of gait assessment and facilitate quantification 
of outcomes (Sivarajah et al., 2017) 
1. Identify measures that are valid, reliable, and responsive, with 
high clinical utility at all levels of ICF for orthotic evaluation 
in children with CP 
2. Perform psychometric studies for measures that lack proven 
validity and reliability for this purpose 
3. If inadequate measures exist, develop measures to enable 
objective evaluation of orthotic outcomes in this population 
4. Evaluate the effectiveness of initiatives to implement these 
measurement practices and change clinician behavior 
3. Variability in PT practices 
for AFO prescription 
1. Educate clinicians about current orthotic/tuning 
literature (may promote integration of current 
literature and use of common terminology in 
practice) 
1. Develop best practice statement to support evidence-informed 
decision-making, similar to Best Practice Statement 
Following Stroke (National Health Service Quality 
Improvement Scotland, 2009)  
2. Evaluate efficacy of different types of AFOs to support future 
development of clinical guidelines  
4. Most follow-up adjustments 
do not appear to address 
impairments, activity, or 
participation goals 
1. Increase clinician knowledge of tuning (may 
help PTs to address biomechanical goals of the 
AFO) 
2. Support collaboration between PT and orthotist 
3. Consider how follow-up adjustments may 
address orthotic goals 
1. Evaluate efficacy of AFO-FC tuning 
2. Simplify and clarify tuning processes to improve accessibility 
(Nicola Eddison et al., 2015) 
3. Examine the relationship between tuning and 
activity/participation 
aEdinburgh Visual Gait Score, bCanadian Occupational Performance Measure, cChildren's Assessment of Participation and Enjoyment; dPediatric 
Community Participation Questionnaire; AFO-FC: AFO-footwear combination
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assessment measures. Clinical outcomes and confidence for decision-making would likely 
benefit from examining topics such as how much passive ankle dorsiflexion ROM is required to 
use a hinged AFO without compensatory foot motion, and the validity and reliability of 
observing shank kinematics to inform prescription decisions. 
4.5.4 Increase study and knowledge about tuning 
AFO-FC tuning provides another example of the potential link between knowledge and 
practice. Several respondents described thinking that solid AFOs can impair gait or hinder 
function– an observation that may be associated with failing to tune the AFO-FC (Bjornson et 
al., 2016; Bowers & Ross, 2009; Owen, 2010). Although tuning has been recommended to 
optimize biomechanics and function (e.g., sit to stand), only 10% of our respondents described 
this practice. Most AFO adjustments seemed to involve comfort and fit, rather than objective 
evaluation for the purposes of biomechanical optimization. This implies the lack of a clear 
relationship between what PTs evaluate on follow-up and the adjustments they make, beyond 
simply enabling the child to tolerate wearing the AFO. It is possible that PTs did not report 
tuning because the orthotist performs this function; however, a survey of orthotists in the United 
Kingdom (Eddison et al., 2015) concluded that only about half of them tuned AFO-FCs, and that 
knowledge of the topic was poor. Therefore, outcomes may improve as PTs and orthotists 
increase their knowledge of tuning and incorporate tuning into routine practice (Table 4.3). More 
broadly, increasing PTs’ knowledge about AFO prescription may also contribute to improved 
confidence for making orthotic decisions. 
A limitation of survey methodology is the inability to draw causal inferences from the 
responses or ask clarifying questions. For example, our questions did not specifically query the 
types of ROM (active, passive, dynamic) respondents evaluated, yet this information may have 
provided further insights. Some comments suggested confusion about altering the AA-AFO 
versus AFO-FC tuning, possibly implying a need for common language to facilitate 
communication; however, our methodology does not afford examination of respondents’ 
knowledge levels. Finally, it is not possible to know the percentage of the population that 
participated in the survey, although all provinces were represented. In 2012, 849 PTs in Canada 
reported pediatrics as their primary employment setting (Canadian Institute for Health 
Information, 2013); however, our exclusion criteria further constrained the size of this 
population.  
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4.6 Conclusions 
The results of this survey suggest that PT evaluation for AFO prescription primarily 
focuses on non-standardized, impairment-level measures, but most PTs also consider 
participation-level information. Evaluation may include standardized or objective measures of 
gross motor function, strength, and tone; however, gait evaluation appears to be primarily non-
standardized. While PTs may evaluate similar constructs to inform prescription 
recommendations, our results suggest a lack of confidence and discrepant interpretations of 
assessment findings. Inconsistent orthotic practices amongst PTs may reflect differences in skills 
or knowledge, as well as attempts to individualize prescriptions. Confidence, consistency, and 
orthotic outcomes may be enhanced by integrating current knowledge into practice, developing 
best practice guidelines, and developing standardized tools to assess the effects of AFOs on 
participation. In addition to identifying these recommendations for clinical practice, the findings 
provide a basis for future research aimed at helping clinicians use evaluation measures more 
effectively to optimize AFO prescriptions for children with CP.  
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CHAPTER 5: EFFECT OF THE ANKLE ANGLE IN AN ANKLE-FOOT ORTHOSIS ON 
GAIT BIOMECHANICS FOR CHILDREN WITH CEREBRAL PALSY 
5.1 Abstract 
Introduction: For children with cerebral palsy (CP) and equinus, the conventional practice of 
setting the ankle angle in an ankle-foot orthosis (AA-AFO) at 90˚ may not fully accommodate 
the length and stiffness of the gastrocnemius muscle. Instead, determining the AA-AFO based on 
clinical gastrocnemius measures may better reflect the dynamic demands of gait. Therefore, this 
study examined the effects of individualizing the AA-AFO on gait and functional mobility for 
children with CP and equinus, compared to their usual AFOs. Methods: Ten children with CP 
and equinus (6-18y; GMFCS I-III; 15 limbs with AFOs), and a reference group of 15 typically-
developing (TD) children (6-18y) participated. For the children with CP, solid AFOs with 
individualized AA-AFOs (iAA-AFOs) were fabricated, accommodating gastrocnemius length 
and stiffness (range=5˚-25˚ plantarflexion). These study AFO-footwear combinations were 
statically aligned to standardize the location of the ground reaction force at temporal midstance 
and compared with the children’s usual AFOs using three-dimensional gait analysis. TD children 
grouped into three age-bands (6-8y; 9-13y; 15-18y), walked in shoes only. Peak values and Gait 
Variable Scores (GVS) for joint and segment kinematic and kinetic variables were calculated for 
stance phase. Confidence intervals (90% CI) were used to categorize responses to the iAA-AFO 
compared to the Usual AFO for each variable as positive, negative, or equivocal relative to TD 
data, for each affected leg. Results: Net responses to the iAA-AFOs were positive for 60% of 
limbs, and negative for 40%. The greatest benefits were observed at the knee. The variables that 
were most often affected negatively were: foot-floor angle and vertical ground reaction force. 
Discussion: Individualized AA-AFOs may improve knee kinematics and kinetics for some 
children with equinus, compared to conventionally-prescribed AFOs. The range of responses 
highlights the need for objective gait evaluation after fitting of the iAA-AFO, and AFO-footwear 
combination tuning to optimize individual outcomes. Future research may identify factors that 
predict children’s responses to iAA-AFOs and inform development of evidence-based clinical 
practice guidelines. This information can assist clinicians in making evidence-based 
individualized AFO prescription decisions.  
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5.2 Introduction 
Cerebral palsy (CP) describes a group of permanent motor disorders that result from an 
injury to the developing brain either before or shortly after birth (Rosenbaum et al., 2007). 
Children with CP demonstrate a range of motor impairments, including hypertonicity, weakness, 
and poor motor control. The most common musculoskeletal impairment affecting this group is 
equinus deformity (Cornell, 1985) which is associated with triceps surae spasticity and shortened 
length (i.e., static or dynamic contracture), as well as functional gait quality impairments such as 
excessive plantarflexion in stance phase, poor swing leg clearance, and impaired balance and 
stability (Davids, 2009; Perry & Burnfield, 2010; Svehlik, Zwick, Steinwender, Kraus, & 
Linhart, 2010; Wren, Do, & Kay, 2004; Wren, Rethlefsen, & Kay, 2005). Altered talocrural 
motion and hindfoot malalignment associated with equinus may influence the development of 
excessive midfoot motion, resulting in lever arm dysfunction and pain (Karas, 2002; Maurer et 
al., 2013). This muscle shortening may alter the plantarflexors’ length-tension curves and reduce 
their ability to produce force (Davids, 2009; Foran, Steinman, Barash, Chambers, & Lieber, 
2005; Lieber, 2002). Foot deformity and altered biomechanics may lead to chronic overuse and 
pain, and affect long-term ambulation outcomes in individuals with CP (Bleck, 1987; Bottos & 
Gericke, 2003; Davids, 2009; Jahnsen et al., 2004; Murphy et al., 1995; Opheim et al., 2009).  
Ankle-foot orthoses (AFOs) are one of the most common non-operative interventions 
prescribed to address these concerns (Novacheck, 2008; Wingstrand et al., 2014). Mechanically, 
AFOs can help restore normal joint motion and walking patterns for children with equinus by 
compensating for weakness and hypertonicity (especially ankle plantarflexor and dorsiflexor 
muscle weakness and gastrocnemius hypertonicity), and redirecting the ground reaction force 
vector to optimize knee and hip kinematics and kinetics (Butler et al., 2007; Butler & Nene, 
1991; Meadows et al., 2008; Novachek et al., 2009; Uustal, 2008). 
In order for AFOs to achieve the optimum effect for each child, the child’s individual 
characteristics (gait pattern, clinical examination) should be matched to the mechanical 
properties and design of the orthosis (Davids et al., 2007; Singerman, Hoy, & Mansour, 1999). 
Ideally, the design is determined collaboratively by the team and outlined in the prescription 
(Kane et al., 2018; Uustal, 2008). An important and often overlooked aspect of individualized 
AFO prescription is the angle of the ankle joint within the AFO (AA-AFO) (Jagadamma et al., 
2015; Ridgewell, Dobson, Bach, & Baker, 2010). The AA-AFO is conventionally set at 90˚, in 
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an attempt to maintain ankle flexibility or prevent ankle plantarflexion contracture, while 
allowing gait with a plantigrade foot (i.e., foot flat on the ground). However, this convention is 
not substantiated by evidence, and is likely based on an erroneous assumption that a 90˚ ankle 
with vertical shank will help the knee to extend in stance phase (Eddison & Chockalingam, 2013; 
Owen, 2010). This may present a problem for children with equinus, as the orthosis requires 
ankle dorsiflexion to 90˚ during gait (or further if a hinged or flexible design is prescribed), 
regardless of the severity of gastrocnemius hypertonicity or contracture.  
If the AA-AFO does not fully accommodate the length and tone of the gastrocnemius 
muscle – which spans the knee, talocrural, and subtalar joints – several compensations are 
possible. Knee extension may be limited at initial contact (IC) (thus preventing IC with the heel) 
or during stance (Karas, 2002; Meadows et al., 2008; Nuzzo, 1983; Owen, 2010). As well, 
subtalar pronation may compensate for restricted talocrural dorsiflexion. When the subtalar joint 
pronates, the alignment of the axes of the talonavicular and calcaneocuboid joints become more 
parallel to allow more dorsiflexion at the forefoot and midfoot (transverse tarsal or mid-tarsal 
joint) compared to when the subtalar joint is in neutral or supination (Elftman, 1960; Johanson et 
al., 2014; Sammarco & Hockenbury, 2001). If the ankle lacks dorsiflexion ROM, the stretching 
force applied during dorsiflexion motion is more likely to stretch the small, extensible ligaments 
of the midfoot than the Achilles tendon (Karas, 2002). This makes it difficult to selectively target 
stretching forces to the talocrural joint and suggests that casting the ankle in a position of 
excessive dorsiflexion (judged relative to the anatomy of the individual’s foot and ankle) may 
promote hyperpronation and/or midfoot break, potentially contributing to lever arm dysfunction 
and long-term pain. Recently, this rationale has led some authors to raise concerns about the 
practice of positioning the ankle in angles of dorsiflexion that exceed the measured 
gastrocnemius length (Eddison & Chockalingam, 2013; Meadows et al., 2008; Owen, 2010; 
Ridgewell et al., 2010). A few authors report using plantarflexed AA-AFOs (Harrington et al., 
1984; Nuzzo, 1983, 1986; Owen, 2004b), although they do not clearly describe the rationale for 
determining the AA-AFO. Most studies do not report the AA-AAO, or use a 90˚ ankle angle for 
all children regardless of clinical findings, suggesting that the rationale for determining the AA-
AFO varies and does not consistently consider the length of gastrocnemius (Eddison & 
Chockalingam, 2013; Ridgewell et al., 2010). 
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Thus, for children with CP, orthotic intervention may be more effective when the AA-
AFO is individualized based on the length and stiffness of the child’s plantarflexor muscles 
(Eddison & Chockalingam, 2013; Jagadamma et al., 2015; Owen, 2010); however evidence-
based consensus or guidelines regarding the AA-AFO do not exist.(Jagadamma et al., 2015; 
Kane et al., 2018) A clinical algorithm has been proposed to determine the AA-AFO (Owen, 
2005); however to date it has not been evaluated in a controlled experiment. Therefore, this study 
aimed to explore the effects of individualizing the AA-AFO for children with CP using this 
algorithm; we compared the effects of the individualized AA-AFO to current conventional AFO 
prescription practices by examining lower extremity gait kinematics and kinetics, and functional 
mobility. We hypothesized that better control of the ankle joint using a solid AFO, in a position 
that accommodated the child’s gastrocnemius length and stiffness, would promote better 
kinematics and kinetics at the knee joint and to a lesser extent at the hip. We also expected these 
improvements would be reflected by more typical foot and shank segment kinematics. We did 
not expect that functional mobility or spatio-temporal parameters would be adversely affected.  
5.3 Method 
5.3.1 Participants  
Children with CP were recruited from the province’s two tertiary rehabilitation facilities 
and the two associated orthotics departments. Children were invited to participate if they met the 
following criteria: 1) aged 5-18 years; 2) diagnosis of spastic CP; 3) gastrocnemius contracture 
of 5˚ or greater, measured with the knee fully extended (Owen, 2005, 2010); 4) Gross Motor 
Function Classification System (Palisano et al., 2007) level I-III; 5) had worn an AFO for >6 
months; 6) able to walk 8 meters 20-30 times without AFOs; 7) able to cooperate with the testing 
procedure and follow simple commands in English; 8) had not undergone orthopaedic surgery or 
botulinum toxin injection in the past 6 months.  
Typically-developing (TD) children were recruited via word of mouth and web-based 
advertisement to the university community. These children met the following criteria: 1) aged 5-
18 years; 2) born full-term (i.e., >37 weeks of gestation) with no complications; 3) no injury or 
condition that affected walking or balance ability; and 4) able to cooperate with the testing 
procedure and follow simple instructions in English. These children were grouped into 3 age 
bands (6-8, 10-13, and 15-18 years), to describe the gait of TD children using the same 
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methodology as the children with CP. The first author spoke to parents/guardians by phone to 
screen potential participants in both groups, to ensure they met the inclusion criteria. 
The study was approved by the Research Ethics Board of the University of Saskatchewan 
and the Regina Qu’Appelle Health Region. All children provided informed assent and 
parents/guardians provided written informed consent to participate. 
5.3.2 Procedures 
5.3.2.1 Clinical assessment of participants with CP and determination of individualized 
AA-AFO 
A registered physical therapist with 15 years of experience in pediatric rehabilitation 
(KJK) conducted a clinical assessment of each participant with CP. The clinical assessment 
included evaluation of each child’s lower limb alignment, gait pattern, range of motion, and 
spasticity (Boyd & Graham, 1999; Cusick, 2006, 2009; Owen, 2016). The child’s individualized 
AA-AFO (iAA-AFO) was determined by examining the child’s gastrocnemius length and 
stiffness (Owen, 2005, 2010, 2018). According to this procedure, the child was positioned in 
supine. Dorsiflexion ROM was measured with the foot in full pronation, neutral, and supination, 
with the knee extended, and the most restricted measurement determined the iAA-AFO (Owen, 
2005, 2018). Measurements of ankle dorsiflexion range of motion (ROM) were obtained using 
digital photography with an iPad (Apple Computers, Inc., Cupertino, CA) and a goniometry 
application (app) designed for use on a mobile phone or tablet (DrGoniometer, CDM S.r.L, Este, 
Italy). The orthotist took the photograph with the iPad positioned parallel with the child’s lower 
leg and vertical (as determined by the DrGoniometer app), while the physiotherapist held the 
ankle at end range. The app was then used to calculate the sagittal plane angle between the shank 
(a line running approximately from the fibular head to lateral malleolus) and hindfoot 
(calcaneus). This goniometer app has been shown to improve the reliability of ROM 
measurements compared to traditional goniometry (Ferriero et al., 2013). The physiotherapist 
confirmed the app’s measurements using a universal goniometer (using the same landmarks as 
for the measurement with the goniometry application), and they were within 5˚ of each other.  
5.3.2.2 Orthoses and footwear 
A certified orthotist custom-fabricated the study orthoses with iAA-AFOs for all children 
in the CP group. Standardized specifications were provided to the orthotists (Table 5.1), to create 
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a solid ankle AFO with an iAA-AFO (as determined above). The iAA-AFO orthoses were made 
with 3/16” (4.8mm) polypropylene, with trimlines distal to the metatarsophalangeal joints and 
anterior to the malleoli. Carbon fiber ribs were added at the orthotist’s discretion to increase the 
stiffness for larger children. Each orthosis was fabricated with tibial and ankle straps (anti-
supination straps where the orthotist deemed it appropriate), and an ethylene-vinyl acetate (EVA) 
wedge under the heel to create a shank to bench angle of 0˚ (i.e., the shank segment of the AFO 
is aligned vertically, when sitting on a flat surface or “workbench”). This angle allowed the 
researchers a consistent neutral starting point from which to add wedges and tune the AFO-FCs. 
All AFOs were fabricated and fit by one of three orthotists in two orthotic departments. The 
physical therapist (KJK) was present at all casting appointments to confirm the iAA-AFO during 
and after casting.  
Wearing shoes has been demonstrated to affect walking speed, step length and kinematics 
in children (Wegener et al., 2011). Therefore, all participants (children with CP and the TD 
group) wore the same brand/style of shoe (Rebound mid-top skate shoe, DC Shoes, Inc.) during 
the test, except one participant with CP. Participant 10 wore women’s New Balance 636 extra 
wide shoes with 5mm pitch (New Balance, Boston, MA) because she was unable to comfortably 
wear the study shoes. The study shoe worn by the other children had a flat sole profile, neutral 
heel, and a 0mm pitch. It was selected because it was available in a range of sizes from toddler to 
adult, and because the depth accommodated a variety of wedge heights while allowing the shoe 
to be laced high enough to minimize motion of the brace in the shoe. 
5.3.2.3 Static alignment of AFO-footwear combinations (AFO-FCs) 
Each of the Usual (except for the hinged and flexible AFOs) and iAA-AFOs was 
statically aligned by the first author prior to gait testing. Participants stood with both feet on a 
force plate (50.8 cm x 46.3 cm, OR6-7, AMTI, Watertown, MA) while the GRF vector was 
visualized using direct video overlay (Nexus 2.5, VICON, Centennial, CO; A620FC Digital 
Camera, Basler AG, DE). High density EVA heel wedges were temporarily secured to the sole of 
the shoe to adjust the position of the GRF vector in the sagittal plane until it was aligned through 
the middle of the foot and the knee joint centre (Owen, 2004, 2014; Eddison, 2017). Once the 
heel wedges were added, a shoe raise was secured to the bottom of each shoe, as indicated to 
equalize the child’s leg lengths, accounting for any asymmetries due to measured physiological 
differences and/or AA-AFOs or heel wedges. Leg lengths were checked again in standing, as the 
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children were unable to lay supine while wearing the markers and EMG equipment. Finally, 
bilateral point loading rockers made of ¼” (6.35mm) high density plastazote (80% of the shoe’s 
length) were secured underneath the sole (Jagadamma et al., 2015; Owen, 2018). This was done 
to give the participants a simulated third (toe) rocker where the trim lines distal to the MTPs did 
not allow an anatomical third rocker (Owen, 2018). The final shank to vertical angle (SVA; 
calculated as the angle of the anterior tibia relative to vertical) was measured with the child 
standing still using the DrGoniometer app (Figure 5.1). The GRF location relative to the knee 
was confirmed using the forceplate and direct video, to complete the static alignment process.  A 
period of acclimatization (10 – 15 minutes) was provided to ensure that the child felt comfortable 
walking in each AFO-FC. 
 
 
Table 5.1. Specifications provided to orthotists for fabrication of the iAA-AFOs 
1. Ankle angle determined during the casting: Right: _________   Left: ___________  
[completed by PT during visit] 
2. Landmarks for ankle angle measurements used by PT during physical exam:  
-“line of the leg”: fibular head to lateral malleolus  
-“line of the foot”: lateral hindfoot, along the calcaneus (up to the base of the 5th 
metatarsal)  
To ensure consistency of the ankle angle in the AFO, please check these measurements 
the same way during casting, after the cast comes off, after any rectification of the 
cast, and to check the ‘positive’ once the AFO is fabricated 
3. Shank to bench angle of finished AFO: 0˚ (add EVA wedge (approximately equal to the 
amount of ankle plantarflexion in 1) under the heel, to achieve this angle) 
4. Cast with MTPs extended 
5 Full toeplate length 
6. Solid AFO – rigid enough that the ankle will not bend during walking 
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Figure 5.1. Screen shot of SVA measurement using DrGoniometer app. Photo shows a statically aligned 
AFO-FC, with label added to indicate location of wedge (used to adjust SVA) and point loading rocker. 
 
 
5.3.2.5 Functional mobility assessments 
Participants with CP completed three functional mobility measures – the Pediatric 
Balance Scale (PBS; Franjoine, Gunther, & Taylor, 2003), and 10-meter walk test at self-
selected (10mSSWT) and fastest (10mFWT) speeds (Kane, Lanovaz, Bisaro, Oates, & 
Musselman, 2016; Thompson et al., 2008) – in each of the two AFOs. The order of both the tests 
and the AFO conditions were randomized to mitigate the effects of fatigue and practice. The PBS 
is a standardized measure of functional balance, used to evaluate changes in function for children 
with CP. The PBS assessment was video-recorded and scored off-line by the first author (KJK). 
The PBS (Chen et al., 2013; Verbecque, Lobo Da Costa, Vereeck, & Hallemans, 2014) and the 
10mSSWT and 10mFWT (Kane et al., 2016) have been shown to be reliable for children with 
CP. 
5.3.2.4 Gait analysis 
Three-dimensional motion analysis was conducted using an 8-camera motion capture 
system (Vicon Nexus, Centennial, CO) with a custom, full-body marker set, and two force plates 
(AMTI, Watertown, MA). Participants walked at a comfortable self-selected speed along a 
Point loading rocker 
 
Wedge 
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walkway that was 10 meters long and 3 meters wide. Children with CP walked in three 
conditions, in randomized order: 1) shoes only; 2) usual AFO(s); and 3) iAA-AFO(s). TD 
children walked with shoes only. For each condition, trials were conducted until at least six force 
plate contacts were obtained with each foot. Children were not informed about the force plates, 
in order to reduce the likelihood that they would change their gait pattern to step on them. Rest 
periods were provided as needed to mitigate fatigue effects. None of the markers were replaced 
in between conditions. Kinematic data were sampled at 100 HZ and force plate data were 
sampled at 2000Hz. 
A total of 47 reflective markers (a combination of 9 mm and 14 mm diameter markers) 
were used, nine of which tracked upper body points that were used for visualization only. Of the 
remaining 38 lower body markers, 10 were used only in the calibration process and removed for 
data collection. The 28 tracking markers for the lower limb consisted of clusters of four markers 
fixed to rigid thermoplastic molded plates that were attached to the lateral aspect of each thigh 
and shank using two-sided tape and medical wrap. For some of the smaller children (n=2), the 
four shank markers were fixed directly on the skin rather than using the rigid cluster. A rigid 
four-marker cluster was fixed to the sacrum using a belt and two-sided tape in order to track 
pelvic motion. Three markers in a triangular configuration were fixed to the lateral aspect of each 
shoe near the rear foot and a marker was placed on the posterior heel of each shoe. The 10 
calibration-only markers were placed on the medial and lateral femoral condyles, the medial and 
lateral malleoli and on the dorsal shoe just above the second metatarsal (i.e. a toe marker). 
Segmental coordinate systems were defined for the lower limbs using a combination of 
static calibration data and functional joint centre calculations. Participants first stood in a static 
calibration pose with feet shoulder width apart in the shoe-only condition without any AFO such 
that the malleoli markers were visible. Ankle joint centres were defined as the midpoint between 
markers placed on the malleoli and expressed relative to the shank clusters. The participants then 
performed standing unweighted knee flexion/extension movements for each limb to estimate the 
flexion axis of the knee (O’Brien, Bodenheimer Jr, Brostow, & Hodgins, 2000) and the knee 
joint centre was estimated by projecting the midpoint of the femoral condyle markers on to the 
closest point on the estimated flexion axis (Hagemeister et al., 2005). Finally, participants rotated 
each leg through an unweighted hip range of motion (forward/backwards, side-to-side) in order 
to estimate the hip joint centres using data from the thigh and pelvis clusters (Ehrig, Taylor, 
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Duda, & Heller, 2007; O’Brien et al., 2000). Hip joint centres were tracked using the thigh 
clusters.    
The ankle, knee, and hip joint centres and the knee flexion axis were used to establish 
orthogonal segmental coordinate systems for the pelvis, thigh and shank, and segmental 
kinematics were tracked using the clusters. The medio-lateral axis (Y) of the pelvis was defined 
using the hip joint centres while the vertical axis (Z) was set to correspond to the global vertical 
direction during the starting calibration. The medio-lateral axis (Y) of the thigh was set parallel 
to the knee flexion axis while the anterior-posterior thigh axis (X) was defined as the cross 
product of the medio-lateral axis and the line between the knee and hip joint centres.  The shank 
medio-lateral axis (Y) was also set parallel to the knee flexion axis and the shank anterior-
posterior axis (X) was defined as the cross product of the medio-lateral axis and the line between 
the ankle and knee joint centres.  
The shoe and foot were defined as two different coordinate systems that were both 
tracked with the same shoe-based markers.  The shoe coordinate system was defined with a 
vertical axis (Z) parallel to the global axis and the medio-lateral axis (Y) defined as a cross 
product of the vertical axis and a line from the heel to the toe marker.  The foot coordinate 
system was then established by rotating the shoe coordinate system about its medio-lateral axis 
based on the ankle angle within the AFO and the angle of the wedges attached to the shoe. For 
the TD participants, the shoe and foot coordinate systems were identical.     
Three-dimensional joint kinematics were calculated as the relative movement between 
adjacent segments using a YXZ Cardan sequence and flexion/extension angles were reported for 
the hip, knee and ankle joints. Ankle joint kinematics were defined as the relative angle between 
the shank and foot coordinate systems.  Shank-to-vertical kinematics were expressed as the angle 
between the Z axis of the shank and the global vertical axis. Foot-floor kinematics were 
expressed as the angle between the X axis of the shoe coordinate system and the global 
horizontal.   
Kinematic and force plate data were combined using standard inverse dynamics 
techniques (Winter, 2009) to calculate 3D joint moments for the ankle, knee, and hip. Thigh, 
shank and foot body segment parameters for the inverse dynamics calculations were estimated 
using published data (Jensen, 1986). Flexion/extension moments for the hip, knee, and ankle 
were reported. 
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5.3.3 Analyses 
Scores on the PBS, and speed (m/s) on the 10mSSWT and 10mFWT were calculated. 
Within-participant results of each these functional mobility assessments were compared between 
the two AFO conditions using a Wilcoxon signed-rank test for dependent samples. 
Motion analysis data from the cameras and force plates were processed using Vicon 
Nexus 2.0 (Centennial, CO) and custom routines in MATLAB R2017a (MathWorks, Natick, 
MA). Kinematic data were filtered offline using a 4th order Butterworth filter with 10 Hz low-
pass cut-off. This removed the high frequency noise while providing good-quality position, 
velocity, and acceleration data. Six to seven trials were processed in Vicon for each foot and 
condition. Following processing in MATLAB, trials were visually inspected and were excluded 
if there was evidence that the child was walking excessively slowly, was running, turned during 
the step, or stepped on the force plate with both feet. Therefore, three to six trials were included 
for each child for each limb and condition, except for all participants except child 2, for whom 
data for the shoe condition on the unaffected leg was unusable due to technical errors. Kinetic 
data were not collected for participant 9, because her step lengths were too short/variable to 
allow her to contact the force plate with only one foot. Six trials were included for each child in 
the TD group, and the data from this group were combined into the appropriate age band (6-8, 
10-13, or 15-18 years). As there was no difference between right and left legs for the TD group, 
an average of both legs was included. 
Kinematic and kinetic data from each participant were ensemble averaged for each 
condition for the stance phase of the gait cycle. The following peak kinematic variables were 
calculated: knee extension angle (KneeIC), SVA (SVA_IC) and foot-floor angle (FFA_IC) at IC, 
peak joint angles in stance phase for ankle dorsiflexion (AnkleDF), ankle plantarflexion 
(AnklePF), knee flexion (KneeFlex), knee extension (KneeExt), hip flexion (HipFlex), and hip 
extension (HipExt), and SVA (SVA_TMSt) and FFA (FFA_TMSt) at temporal midstance. IC 
was defined as the first contact of the foot with the floor and TMSt was defined as 50% of the 
child’s stance phase. The following peak kinetic variables were calculated: knee moments at 1) 
TMSt (KneeMom_TMSt), and 2) at the average point in the gait cycle where the two peak 
extensor moments occurred for the TD children (20% of stance phase or loading response (LR) 
and 93% of stance phase or terminal stance (TS); KneeMom_LR and KneeMom_TS), and the 
peak hip flexion and extension moments (HipFlex_Mom and HipExt_Mom). Moments at fixed 
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time points were chosen because clear peaks were not consistently present in the kinetic data of 
the children with CP. Spatio-temporal variables were: stride velocity, step length, stride time, 
and stance percent. As an index of overall gait quality, individual gait variable scores (GVS) 
(Baker et al., 2009) were calculated for the entire stance phase for relevant variables: ankle ROM 
(GVS_Ankle), knee ROM (GVS_Knee), hip ROM (GVS_Hip), SVA (GVS_SVA), FFA 
(GVS_FFA), knee moment (GVS_KneeMom), hip moment (GVS_HipMom), and vertical force 
(GVS_VF). Each GVS was calculated as the mean RMS difference between each trial of the 
child’s gait cycle data and the mean of the TD group gait cycle data. Each child’s data was 
compared to the TD data from the appropriate age band.  
Because of the wide variability within the sample, group means were not compared 
(Damiano, 2014). For the children with CP, gait data for each affected limb during the stance 
phase of the gait cycle were analyzed visually and using descriptive statistics. For each limb, the 
mean, SD, and confidence interval (90% CI) were calculated for the Usual and iAA-AFO 
conditions. A difference between conditions was defined as no overlap of the 90% CIs. When a 
difference was detected, if the value of the iAA-AFO condition was closer to the mean of the TD 
data than the Usual condition, this was considered a positive response for the iAA-AFO. iAA-
AFO values farther from the TD mean than the Usual condition were considered negative 
responses. When the 90% CI between conditions overlapped, this indicated no difference 
between conditions (i.e. equivocal). Similarly, if values for both conditions were within one SD 
of the TD mean, the results were also considered equivocal. All comparisons with TD data were 
made to the most appropriate TD age band. The number of responses in each category (positive, 
negative, and equivocal) were summed for each limb for all 25 knee, hip, segment, and 
spatiotemporal variables combined. A limb was considered a net positive responder if more 
variables were positively affected than negatively affected. Conversely, a net negative response 
was recorded if the limb demonstrated more negative than positive responses. If there were equal 
positive and negative responses, or no differences, then the limb was considered an equivocal 
responder. Cohen’s d was calculated using a pooled SD as an effect size measure to quantify the 
magnitude of each positive and negative response for each limb. An effect size of 0.8 or greater 
was considered to be a large effect (Landis & Koch, 1977).  
As the ankle was the target of the experimental manipulation, responses of the three ankle 
kinematic variables were considered separately. Wilcoxon signed-rank test was used to compare 
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Ankle_DF, Ankle_PF and Ankle_GVS between conditions, to confirm the effectiveness of the 
experimental manipulation of the independent variable, induced through individualizing the AA-
AFO.  
Statistical significance for the Wilcoxon tests was set at p<0.05. Analyses were 
completed using IBM SPSS Statistics version 24.0 (IBM Corp., Armonk, NY), and MATLAB 
R2017a (MathWorks, Natick, MA). 
5.4 Results 
Participants were 10 children with CP (6-18 years; median 10y 10m; 6 girls; Table 5.2), 
and 15 TD children (6-18 years; median 12 y 7m; 8 girls). All completed the 3D gait test. Two 
children with CP did not complete the functional tests – one (the youngest participant) due to an 
inability to pay attention by the end of testing and one (the most physically involved participant, 
classified as GMFCS III) due to fatigue.  
5.4.1 Physical assessment 
Physical examination findings for each participant are presented in Table 5.3 and 
Appendices D1, D2, and D3. The median passive dorsiflexion ROM was -12˚ in supination 
(range = -4˚ to -25˚), and 0˚ in both neutral (range = 10˚ to -18˚) and pronation (range=8˚ 
to -20˚).  
5.4.2 Clinical Measures of Balance and Mobility  
5.4.2.1 PBS 
PBS scores in the Usual condition were 47-56 (median = 54.5), and 46-56 (median = 
54.5) in the iAA-AFO condition. Wilcoxon signed-rank test showed no significant difference 
between conditions (Z = -0.828, p = 0.408). Scores for four children decreased in the iAA-AFO  
condition compared to their Usual AFO, three stayed the same, and one improved (median 
change -0.5; range -2 to 2; Figure 5.2A).    
5.4.2.2 10mSSWT 
Median speed was 1.04m/s (0.74-1.32m/s) in the Usual AFOs, and 1.16 m/s (0.74-2.26 
m/s) in the iAA-AFO condition. Wilcoxon signed-rank test showed no significant difference 
between conditions (Z = -.560, p = 0.575). With the iAA-AFO compared to the Usual AFO, 
walking speed was faster for four children (range 0.06-1.17 m/s), slower for three children (0.01-
0.26 m/s), and the same for one child (Figure 5.2B). The median change was 0.03 m/s faster.  
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5.4.2.3 10mFWT 
Median speed was 1.73m/s (1.13-2.33m/s) in the Usual AFO, and 1.59 m/s (0.97-2m/s) in 
the iAA-AFO condition. Wilcoxon signed-rank test showed no significant difference between 
conditions (Z = -1.4, p = 0.161). With the iAA-AFO, compared to the Usual AFO, one child 
performed this test more quickly (0.7m/s), six were slower (0.1-0.4m/s), and one child showed 
no difference in speed (Figure 5.2C). The median change was 0.29 m/s slower.  
5.4.3 Participant AFO Characteristics/Static Alignment of AFO-FCs 
5.4.3.1 Usual orthoses 
Participants habitually wore orthoses on 15 of the 20 limbs (Table 5.4). The types of 
Usual orthoses worn were: 7 articulated AFOs with plantarflexion stop at 0˚ and dorsiflexion 
assist, 3 solid AFOs, 1 carbon fiber AFO (ToeOFF®, Allard USA, Rockaway, NJ), 3 
semiflexible AFOs (FlexiSport, Cascade DAFO, Ferndale, WA), and 1 supramalleolar orthosis. 
The AA-AFOs of the Usual AFOs were all 0˚, except for 2 semi-flexible AFOs (10˚ and 3˚ 
plantarflexion), and 2 solid AFOs (5˚ and 10˚ plantarflexion). The solid and articulated AFOs 
were custom-fabricated from 3/16” polypropylene. None of the Usual AFOs had ribs or carbons, 
and all had full-length toe plates and trim lines proximal to the MTP joints. All had shank to 
bench angles of 0˚ (created using EVA wedges where the AA-AFO was <0˚), except for one of 
participant 4’s AFOs, which was reclined 5˚ relative to vertical. Participants’ SVAs measured 
while standing in these AFOs ranged from 5˚ to 20˚ (median=10˚). 
5.4.3.2 iAA-AFOs 
The median ankle angle for the iAA-AFOs was 15˚ plantarflexion (range= 5˚-25˚). Table 
5.4 details the iAA-AFOs and the adjustments made during static alignment of the AFO-FCs. 
Participants’ SVAs, measured while standing in these AFOs, ranged from 9˚ to 18˚ 
(median=12˚). For some children the SVA was more inclined (up to 12˚ more inclined) than with 
the Usual AFOs, and for other children it was less inclined (up to 8˚ less inclined; median= 2 
more inclined). 
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Table 5.2. Characteristics of participants with CP. 
 
Note: Children with bilateral CP wore orthoses on both legs, and children with unilateral CP wore an 
AFO on the affected limb. F: Female; M; male; y: years; m: months; GMFCS: Gross Motor Function 
Classification System 
Child Age Sex 
Diagnosis (affected 
limb) 
GMFCS 
Height 
(cm) 
Weight (kg) 
1 17y 11m F Bilateral II 156.5 63.9 
2 6y 8m M Unilateral (Right) I 114.5 20.5 
3 16y 7m F Bilateral I 151.4 63.4 
4 9y 10m F Bilateral II 134.5 46.4 
5 7y 7m F Unilateral (Left) I 119.5 22 
6 14y 11m M Unilateral (Right) I 153 44.5 
7 11y 10m M Unilateral (Right) I 153 43.8 
8 6y 5m M Unilateral (Right) I 119.5 21.3 
9 6y F Bilateral II 102 14.8 
10 17y F Bilateral III 141 49.7 
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Table 5.3. Characteristics of the participants with CP: ankle dorsiflexion (DF) range of motion 
measured with the foot in full supination, subtalar joint neutral, and full pronation.   
n/a = not applicable (i.e., child did not wear an AFO on this limb and ROM was not tested); negative 
numbers indicate a plantarflexed angle of the ankle; positive values indicate a dorsiflexed ankle angle  
 
 
  
Child 
 
DF in 
supination  
 
DF in neutral  
 DF in 
pronation  
 AA of iAA-
AFO 
Left Right  Left Right  Left Right  Left Right 
1 -15˚ -20˚  -11˚ -18˚  1˚ -20˚  -15˚   -20˚ 
2 n/a -15˚  n/a -17˚  n/a -12 ˚  n/a -15˚ 
3 -6˚ -18˚  7˚ 1˚  1˚ 4˚  -5˚ -20˚ 
4 -4˚ -12˚  -7˚ -4˚  -5˚ -15˚  -5˚ -10˚  
5 -4˚ n/a  -4˚ n/a  1˚ n/a  -5˚ n/a 
6 n/a -8˚  n/a -4˚  n/a -4˚  n/a -12˚ 
7 n/a -25˚  n/a 4˚  n/a -15˚  n/a -25˚ 
8 n/a -11˚  n/a 0˚  n/a -9˚  n/a -15˚ 
9 -4˚ -14˚  10˚ 2˚  4˚ 6˚  -5˚ -15˚ 
10 -18˚ -10˚  10˚ 2˚  8˚ 0˚  -20˚ -12˚ 
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Figure 5.2. Individual results of the: A. Pediatric Balance Scale, B. 10-meter Walk Test at Self-Selected 
Speed (10mSSWT), and C. 10-meter Walk Test at Fastest Speed (10mFWT) for the Usual and 
Individualized ankle angle in the ankle-foot orthosis (iAA-AFO) conditions for the eight participants with 
CP who completed these measures. Child IDs are indicated on each graph.  
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Table 5.4. Characteristics of the Usual and iAA-AFOs and adjustments made during static alignment process.   
Child 
(Limb) 
Usual AFOa  iAA-AFO orthosisb 
AFO Type 
AA-AFOd 
(height of 
heel wedge) 
Other features 
Additions 
Final 
SVA 
iAA-AFOd 
(height of 
heel 
wedge) 
Other 
features 
Additions 
Final 
SVA Heelc 
Through 
raise 
Heelc 
Through 
raise 
1(R) 
Articulatede 
 
0⁰ (rest in 
25⁰ due to 
DF assist 
joints) 
- 0 0 20⁰ -15⁰ (4 cm) Ribs 0 0 12⁰ 
1(L) 
Articulatede 
 
- 0 0 17⁰ 
-20⁰ (4.5 
cm) 
Ribs 0 0 11⁰ 
2 (R) Solid -10⁰ (2.4 cm) 
Trim lines distal 
to MTPs 
5⁰ 
(1cm) 
1cm 9⁰ -15⁰ (3 cm) - 10⁰  5mm 10⁰ 
3 (R)  Solid -5⁰ (1.5 cm) - 
2.5⁰    
(5 mm) 
0 10⁰ 
-20⁰ (4.5 
cm) 
- 0 7mm 12⁰ 
3 (L) SMO 0⁰ - 0 0 10⁰ 
-5⁰ (1.5 
cm) 
- 0 1.4cm 13⁰ 
4 (R) 
Semi-
flexiblef 
 -3⁰ (0.7cm) 
0.5cm medial 
forefoot post; 
SMO insert, 
forefoot strap 
0 0 17.5⁰ -5⁰ (0.8cm) 
12⁰ forefoot 
equinus 
5⁰ 1cm 18⁰ 
4 (L) 
Semi-
flexiblef 
-10⁰ (1cm)  
SBA 5⁰ recline; 
0.5cm medial 
forefoot post; 
SMO insert, 
forefoot strap 
0 0 10⁰ 
-10⁰ 
(1.2cm) 
15⁰ forefoot 
equinus 
5⁰ 1cm 14⁰ 
5 (L) Solid 0⁰ 
Trim lines distal 
to MTPs; SBA 
10⁰  
7⁰ (1.3 
cm)  
1.4 cm on 
right leg 
11⁰ 
-15⁰ (1.7 
cm) 
- 5⁰ 
2 cm on 
right leg 
9⁰ 
6 (R) 
Semi-
flexiblef 
0⁰ (1cm) 
SMO insert with 
1cm lateral 
forefoot post 
0 5mm 8⁰ -12⁰ (3cm) - 0 
3 cm on 
left leg 
10⁰ 
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7 (R) 
Carbon 
fiberg 
0⁰ - 0 
1.5 cm on 
left leg 
10⁰ 
-25⁰ (6.5 
cm) 
- 5⁰ 
5 cm on 
left leg 
12⁰ 
8 (R) Articulatede 0⁰ Toe strap 0 
5mm on 
left leg 
10⁰ 15⁰ (3 cm) - 0 
3cm on 
left leg 
10⁰ 
9 (R) Articulatede 0⁰ - 0 1cm 5⁰ 
15⁰ 
(2.5cm) 
- 0 0 10⁰ 
9 (L) Articulatede 0⁰ - 0 0 10⁰ 5⁰ (1cm) - 0 1.5cm 10⁰ 
10 
(R) 
Articulatede 0⁰ (rest in 
25⁰ DF due 
to DF assist 
joints) 
Casted in 
calcaneovarus 
with 15⁰ lateral 
forefoot & 
hindfoot post 
0 0 5⁰ 
12⁰ (2.5 
cm) 
Ribs 
5⁰ 
(1.4cm) 
0 17⁰ 
10 (L) Articulatede 0 0 5⁰ 
20⁰ (3.5 
cm) 
Ribs 
5⁰ (1.4 
cm) 
0 14⁰ 
 
PF: Plantarflexion; DF: Dorsiflexion; SMO: Supramalleolar orthosis; SBA: shank to bench angle; MTP: metatarsophalangeal joints; PLR: Point 
loading rocker 
aAll Usual AFOs had an SBA 0⁰, trim lines proximal to MTPs, and PLRs were added at 80% where trimlines were distal to MTPs  
bAll iAA-AFOs were solid AFOs, with trimlines distal to MTPs, PLR at 80%, toes 90⁰ to shank. 
cAll footwear had a heel-sole differential (HSD) of 0mm, except for Child 10, whose HSD was 5mm. 
dArticulated AFOs were custom-fabricated from 3/16” polypropylene with DF assist and PF stop, an AA-AFO of 0⁰, and SBA of 0⁰ unless 
otherwise specified  
eFlexiSport, Cascade DAFO, Ferndale, WA; fToeOFF®, Allard USA, Rockaway, NJ 
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5.4.4 Kinematics and Kinetics  
5.4.4.1 Ankle kinematic variables 
Median peak dorsiflexion ROM (AnkleDF) in the Usual AFOs was 12˚ (range = -6˚ to 
45˚). In the iAA-AFOs, AnkleDF was -12˚ (range = -20˚ to 3˚). Median peak plantarflexion 
ROM (AnklePF) in the Usual AFOs was -2˚ (range = -18˚ to 16˚), and in the iAA-AFO the 
median was -19˚ (range = -9˚ to -33˚). A Wilcoxon signed-rank test confirmed that the 
differences between conditions were significant for both AnkleDF (Z = -3.124, p = 0.002) and 
AnklePF n (Z = -2.897, p = 0.004). The median GVS_Ankle scores in the Usual AFOs (median 
= 9; range = 4-25) and in the iAA-AFOs (median = 24; range = 11-32) were significantly 
different ((Z = -3.067, p = 0.002).  
5.4.4.2 Knee, hip, segment, and spatiotemporal variables 
Overall, of the 15 limbs, 9 (60%) were positive net responders, and 6 (40%) were 
negative net responders. (Table 5.5 and 5.6). For these 25 variables, 12/15 limbs demonstrated at 
least 1 positive response (median=3; range=0-12), and 11/15 limbs demonstrated at least 1 
negative response (median=1; range=0-9). Most variables were the same for the two AFO 
conditions. 
The variables that were most often affected positively were: KneeExt (40%), GVS_knee 
(33%), KneeMom_TMSt (31%), and KneeFlex (27%) (Table 5.6 and Appendix D3). The 
variables that were most often affected negatively were: GVS_FFA (33%), GVS_VF (23%), 
HipROM (20%), KneeMom_LR (15%), and GVS_KneeMom (15%). There was little effect on 
spatiotemporal variables, and more knee variables were affected than hip variables. There were 
similar numbers of positive and negative effects at the hip. Effect sizes for the positive and 
negative responses ranged from 1.7 to 17.7 and -2.1 to -6.8 respectively, indicating large effects 
where the 90% CI analysis identified a significant response to the iAA-AFO.  
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Table 5.5. Percentage of knee, hip, foot and shank segment, and spatiotemporal variables that 
demonstrated a positive change, negative change, or no change with the iAA-AFO, the net 
response for each limb, and the total (n and %) limbs in each net response category.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R: Right; L: Left 
 
  
Child Limb Positive Negative No Change Net Response 
1 
 
R 4% 0% 96% Positive 
L 8% 36% 56% Negative 
2 R 12% 0% 88% Positive 
3 
 
R 4% 28% 68% Negative 
L 0% 4% 96% Negative 
4 R 20% 4% 76% Positive 
 L 12% 20% 68% Negative 
5 L 0% 4% 96% Negative 
6 R 12% 4% 84% Positive 
7 R 48% 8% 44% Positive 
8 R 4% 0% 96% Positive 
9 R 0% 6% 94% Negative 
 L 24% 0% 76% Positive 
10 R 32% 8% 60% Positive 
 L 28% 20% 52% Positive 
Net responses Positive responders 9 (60%) 
Negative responders 6 (40%) 
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Table 5.6. Individual variable response profiles by limb according to net response: A. Limbs 
with net positive response; B. Limbs with net negative response; C. Limbs with net equivocal 
response. Effect size (Cohen’s d) values inside red and green boxes indicate magnitude of 
positive and negative responses. 
 
 
 
 
 
 
 
A. 
Child (Limb) 1 (R) 2 (R) 4 (R) 6 (R) 7 (R) 8 (R) 9 (L) 10 (R) 10 (L) 
Knee KneeIC   3.3  1.7     
 KneeFlex   2.8    2.7  3.0 
 KneeExt 4.0    2.1  1.7 2.2 17.7 
 GVS_Knee  1.5   2.1  2.6 2.2 8.6 
 KneeMom_LR    1.7 3.7  X  4.1 
 KneeMom_TMSt    2.1 -2.7  X 3.5 2.2 
 KneeMom_TS       X 2.3  
 GVS_KneeMom  2.8     X 2.2 2.0 
Hip HipFlex   3.0  2.1  2.4   
 HipExt    1.6 -1.6 2.1  -1.9 -3.9 
 GVS_Hip        -2.8 -3.6 
 HipExtMom     1.9  X 2.1  
 HipFlexMom       X   
 GVS_HipMom    -2.0   X 2.4  
Segments SVA_IC   2.7  2.7     
 SVA_TMSt   2.3  4.6     
 FFA_IC     4.7    2.8 
 FFA_TMSt     4.5    -3.8 
 GVS_SVA     4.7    -2.4 
 GVS_FFA  1.8       -4.5 
GRF GVS_VF   -2.5    X 1.9  
Spatio-
temporal 
StrideVelocity          
StrideLength     1.7     
StrideTime          
StancePercent          
% Positive 4% 12% 20% 12% 48% 4% 24% 32% 28% 
% Negative 0% 0% 4% 4% 8% 0% 0% 8% 20% 
% Equivocal  96% 88% 76% 84% 44% 96% 76% 60% 52% 
Net response          
  Positive response 
  Negative response 
  Equivocal response 
  Both conditions within normal range 
X Not tested 
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B. 
Child (Limb) 1 (L) 3 (R) 3 (L) 4 (L) 5 (L) 9 (R) 
Knee 
KneeIC 3.9      
KneeFlex 3.1 -3.1  -2.9   
KneeExt -6.8   1.8  -1.4 
GVS_Knee -3.7   -1.6   
KneeMom_LR -4.7 -2.5    X 
KneeMom_TMSt  3.4    X 
KneeMom_TS      X 
 GVS_KneeMom -2.6   -2.3  X 
Hip 
HipFlex       
HipExt       
GVS_Hip       
HipExtMom     -2.4 X 
HipFlexMom -1.8     X 
GVS_HipMom      X 
Segments 
SVA_IC       
SVA_TMSt  -2.9     
FFA_IC  -2.1  6.4   
FFA_TMSt  -2.7  2.2   
GVS_SVA  -2.6     
GVS_FFA -2.2 -3.2 -2.7 -1.6   
GRF GVS_VF -2.0   -2.2  X 
Spatio-
temporal 
StrideVelocity -2.3      
StrideLength -2.4      
StrideTime       
StancePercent       
% Positive 8% 4% 0% 12% 0% 0% 
% Negative 36% 28% 4% 20% 4% 6% 
% Equivocal 56% 68% 96% 68% 96% 94% 
Net response       
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5.5 Discussion 
This study evaluated the immediate effects of an iAA-AFO on gait and functional 
mobility for children with CP and equinus, compared to conventionally-prescribed AFOs. More 
limbs responded positively than negatively, suggesting that this approach can improve gait 
mechanics, although the individual net effect may vary. As hypothesized, the greatest effects of 
the iAA-AFO were seen at the knee. Similar numbers of positive and negative effects occurred at 
the hip, foot, and shank, while spatiotemporal parameters and functional mobility were not 
noticeably affected. This is the first study to explicitly compare the effects of an iAA-AFO and 
conventionally-prescribed AFOs, and the results may assist clinicians in making more evidence-
based orthotic decisions. 
While the AFO literature has focussed primarily on effects at the ankle, our results 
highlight potential proximal effects associated with bracing the ankle in a position that tries to 
account for the length and stiffness of the gastrocnemius muscle. The most common effects of 
the iAA-AFO were more typical knee kinetics and kinematics, including increased knee 
extension at IC and throughout stance phase. These gains may have important implications, 
given that many interventions for children with CP aim to improve knee ROM and gait 
kinematics. Increased knee extension at IC has also been observed after gastrocnemius-soleus 
tenotomies for children with equinus, suggesting an effect on the dynamic coupling of the ankle 
and knee joint (Baddar et al., 2002). It is possible that the mechanism is similar for the iAA-
AFO; however, the effect in our study was not beneficial for all children, and gait mechanics 
appeared worse for some, in comparison to their usual AFOs.  
Some of these equivocal or negative responders may have benefitted from further tuning 
of the AFO-FC to optimize the SVA alignment for walking. The interaction of gastrocnemius 
and GRF alignment relative to the knee is considered to be a primary contributor to several gait 
patterns affecting children with CP (e.g., genu recurvatum; Bauer et al., 2017; and crouch; 
Steele, Seth, Hicks, Schwartz, & Delp, 2010; Steele, van der Krogt, Schwartz, & Delp, 2012); 
however, effective control of sagittal plane ankle motion can allow a solid AFO to realign the 
GRF and normalize joint moments at the knee and hip (Butler & Nene, 1991; Carse, Bowers, 
Meadows, & Rowe, 2014; Meadows et al., 2008). Although we optimized the static alignment of 
the AFO-FC during standing, it is likely that tuning (e.g., adjustments to the AFO-FC to optimize 
the SVA during walking) would have conferred further biomechanical gains for these 
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participants. Indeed, most demonstrated gait patterns that are considered amenable to tuning 
(e.g., knees extended during stance, less than 20˚ of knee flexion at IC) (Butler, Farmer, Stewart, 
Jones, & Forward, 2007b; Jagadamma et al., 2015). Eddison and colleagues (Eddison et al., 
2017) reported that SVAs measured during static standing were equivalent to those seen at 
temporal midstance in the gait cycle; however, we did not find that our statically-aligned SVAs 
were dynamically optimized in temporal midstance in this study. Therefore, standard practice 
following the fitting of an iAA-AFO should include dynamic optimization of SVA alignment 
during walking, as part of the tuning process (Jagadamma et al., 2010; Meadows, 2014; National 
Health Service Quality Improvement Scotland, 2009; Owen, 2010, 2018). 
Adequate AFO stiffness is an additional factor that influences knee and hip mechanics 
(Bowers & Ross, 2009; Kerkum, Buizer, et al., 2015). Visual analysis of the kinematic ankle 
joint data in this study suggested that most of the solid AFOs (both Usual and iAA-AFOs) may 
not have been stiff enough to maximize control of the shank segment and optimize effects at the 
knee and hip joints. For example, ankle plantarflexion at loading response (up to 10˚ of motion in 
some children) may have contributed to increased stance phase knee hyperextension and shank 
recline, as this insufficient stiffness prevented the AFO from facilitating normal shank incline as 
the centre of mass moved forward in midstance. In other cases, the iAA-AFOs allowed up to 15˚ 
of relative ankle dorsiflexion in stance phase, potentially failing to optimize the AFO’s effect on 
knee moments. As the design of the iAA-AFOs in this study reflects accepted clinical practice 
(regarding trimlines, materials, and fit), these observations imply that stiffer AFO designs may 
be necessary to support the achievement of some biomechanical goals.  
A 90˚ AA-AFO is also conventional in clinical practice. This was reflected in the large 
difference between the AA-AFOs of the community-prescribed Usual AFOs and the child’s 
clinically-measured dorsiflexion ROM. As expected, there was a corresponding difference 
between the Usual and iAA-AFO conditions for peak dorsiflexion and plantarflexion ROM, 
consistent with the iAA-AFOs. Therefore, when individualizing the AA-AFO, acknowledgement 
of potential trade-offs may require the team to prioritize orthotic goals. For example, kinematic 
gains at the knee may be associated with the potential for a more plantarflexed position and less 
ankle motion when the AFOs are worn. This possibility may deter clinicians who have concerns 
that plantarflexed AA-AFOs may cause (or fail to address) plantarflexion contractures (Kane, 
Lanovaz, & Musselman, 2018; Kane et al., 2018), even though AFOs have not been shown to 
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increase ankle dorsiflexion ROM or prevent contractures (Bowers & Ross, 2009), and less than 
90˚ of passive ankle dorsiflexion ROM has been identified as a contraindication for a 90˚ AA-
AFO (as well as hinged, dorsiflexion-free AFOs) (Eddison & Chockalingam, 2013; Owen, 2015; 
Ridgewell et al., 2010).  
The algorithm we used in this study explicitly considers the risk of losing ankle ROM in 
the decision-making process (Owen, 2005). The natural history of CP involves development of 
secondary musculoskeletal deformities such as plantarflexion contractures throughout an 
individual’s lifespan (Gage & Schwartz, 2009; Goldstein & Murray, 2001; Rosenbaum et al., 
2007). As such, clinical management plans should be responsive to clinical re-assessment 
findings. Additionally, specifying the duration of wear as part of the AFO prescription provides 
an opportunity to discuss time out of orthoses, when the child’s ankles may move through their 
available ROM (Owen, 2018).  
Clinical algorithms have been used in medicine since the 1970s to describe and 
personalize intervention, and to reduce trial and error decision-making (Federer, Taylor, & 
Mather, 2013; Sox & Stewart, 2015). Algorithms are intended to be simplistic and systematic, 
and are recommended when a variety of responses, patient preferences, and needs exist, and 
options in the decision pathway are unambiguous (Federer et al., 2013; Keffer, 2001). While 
clinicians do endeavour to individualize AFO prescriptions for children with CP (Kane et al., 
2018), decision-making in orthotic management is impacted by numerous factors, many of which 
are yet unknown. Furthermore, the standard approach to decision-making is variable, and relies 
on trial and error and anecdotal evidence (Kane et al., 2018; Morris et al., 2002), indicating a 
clear need for decision-making guidelines such as clinical practice guidelines (CPGs; Davis, 
Goldman, & Palda, 2007; Sox & Stewart, 2015). Algorithms have been included in evidence-
based CPGs to guide complex decision-making in other aspects of rehabilitation management of 
children with CP (Fehlings et al., 2012; O’Neil et al., 2006). Therefore, the development and 
refinement of algorithms such as the one used in this study appear to be a valuable endeavour. 
The algorithm we used to determine the iAA-AFO in this study is the only one of its kind 
for this purpose; however, as it is based on theoretical justification, clinical experience, and 
expert opinion, a systematic literature review and further high quality research would help link 
recommendations with evidence (Sox & Stewart, 2015). The results of this study suggest 
modifying the algorithm’s present end-point to include biomechanical optimization of the AFO-
 80 
 
FC. The variety of responses we observed in this study highlight the need for objective 
evaluation and tuning post-fitting to be prioritized in clinical practice. This suggestion is 
consistent with previous authors who have asserted that the determination of the AA-AFO is a 
first step and prerequisite for biomechanical optimization for gait (Bowers & Ross, 2009; Owen, 
2010, 2018). To this end, a further step may be to create an algorithm to guide visual gait 
analysis for tuning and biomechanical optimization following the fitting of an iAA-AFO. 
5.5.1 Limitations 
Given the small sample size and the variety of Usual AFO types, it is difficult to draw 
conclusions about the reasons underlying the variety of responses to the iAA-AFO. No clear 
patterns emerged that suggested effects related to participant characteristics such as GMFCS 
level, age, or diagnosis. The effects of the iAA-AFOs may have been in part due to differences in 
AFO types tested in the Usual condition. Replication with larger samples, and with solid AFOs 
in the Usual condition, is warranted to examine factors that may predict a child’s response to 
iAA-AFOs. Statistical modelling techniques may also help to identify the factors affecting 
individual responses to an iAA-AFO. 
As this is the first study examining the effects of the AA-AFO, we examined only the 
immediate effects. For many participants, the iAA-AFOs were quite different from their Usual 
AFOs, and their performance may not have reflected their potential. As there is likely an effect 
of practice on gait, further longitudinal research should examine whether kinematics, kinetics, 
and walking speed change with gait training. While we found no significant effect of the iAA-
AFO on PBS scores, spatio-temporal parameters, or the 10mSSWT or 10mFWT, the median 
speed on the 10mFWT decreased 0.29m/s. This change was not statistically significant, but it 
may be clinically meaningful. It is possible that fatigue affected the results, or that children may 
require more practice to become confident walking quickly in a new iAA-AFO. It may also be 
noted that Participant 6 walked much faster in the iAA-AFOs than in his usual AFOs at both 
10mWT speeds (Figure 5.2), suggesting that the test may have questionable validity as a walking 
speed measure in some situation. Longitudinal research should also examine the effects of iAA-
AFOs on community walking and participation in daily activities.  
Finally, the extent to which either AFO controlled pronation and midfoot break is 
unknown. Passive dorsiflexion ROM measurements were greater with the foot pronated than 
supinated for 12 of 15 limbs, and pronation was observed visually during barefoot gait for most 
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children (Appendix D3). Uncontrolled pronation and midtarsal joint dorsiflexion may explain 
how peak ankle dorsiflexion motion in the Usual AFOs surpassed the clinically measured ranges 
for many children. Dorsiflexion in gait is also likely to exceed the passively measured range due 
to the large lever arm and forces in terminal stance; however this motion may be achieved at 
joints other than the talocrural joint (e.g., via subtalar joint pronation or midtarsal joint 
dorsiflexion; Johanson et al., 2014; Karas, 2002). Such chronic repetitive strain may contribute 
to long-term pain, which is a prevalent concern for adults with CP (Bleck, 1987; Jahnsen et al., 
2004). As clinicians may assume that dorsiflexion motion occurs at the talocrural joint in a 
hinged AFO, or with a conventional 90˚ AA-AFO, this issue warrants further exploration. Other 
areas for future longitudinal research include the relationship between gastrocnemius length, foot 
deformity and pain, along with the validity of concerns that positioning an ankle in 
plantarflexion increases the risk of losing ankle ROM.  
5.6 Conclusion 
The results of this study demonstrate immediate beneficial effects of individualizing the 
AA-AFO for some children with CP and equinus, in comparison to community-prescribed 
standard-of-care AFOs. While not all limbs demonstrated gains, almost half improved, consistent 
with previous statements that current AFO prescription practises may be improved (Ries et al., 
2014). These results also highlight the need to individualize orthotic prescriptions, to identify 
and address biomechanical goals specific to the child’s individual physical characteristics. 
Clinical use of an iAA-AFO should be accompanied by objective post-fitting gait evaluation 
(using video or instrumented measures) to tune the AFO-FC and optimize dynamic alignment. 
Future development of evidence-based clinical practise guidelines that incorporate clinical 
algorithms are an important step toward consistent high quality, individualized orthotic care for 
children with CP.   
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CHAPTER 6: GENERAL DISCUSSION AND CONCLUSIONS 
This thesis aimed to improve the evidence guiding AFO prescription for children with 
CP, and to contribute to the development of best practice guidelines for AFO prescription in this 
population. Two studies explored the clinical context in which AFO prescriptions are initiated 
and implemented in Canada; one (Chapter 3) used semi-structured interviews and focus groups 
to examine clinician experiences and the factors that currently influence prescription, and the 
second (Chapter 4) surveyed PTs to understand how outcome measures are used to inform and 
evaluate the prescribed AFO. A third study (Chapter 5) examined the effect of individualizing 
one aspect of the prescription – the AA-AFO – on gait biomechanics and functional mobility for 
children with CP.  
In their results, each of these studies highlighted current opportunities and challenges in 
AFO prescription. Although numerous studies have examined the effects of AFOs in 
laboratories, Chapters 3 and 4 present new information about some of the factors that impact 
their effectiveness in practice. Chapter 3 illustrates the collaborative, iterative, and individualized 
process of AFO prescription, and describes supports and challenges that may impact successful 
orthotic care. This study identified the importance of evaluation in the process of AFO 
prescription, which was further explored in Chapter 4. We found that while PTs attempt to use 
evaluation to individualize prescriptions, the themes arising in Chapter 4 indicated a focus on 
impairment-level measures, inconsistency in evaluation and recommendations, and a lack of 
knowledge and confidence in this area. These findings may help explain reports that AFOs may 
not improve the child’s gait pattern, or in some cases make it worse (Ries et al., 2014); however, 
they also suggest areas for improvement and both chapters offer recommendations for clinical 
practice. Chapter 5 highlights and discusses the potential to improve conventional prescriptions 
using an algorithm approach that is based on biomechanical principles and PT evaluation 
findings for the individual child. In this study, individualizing the AA-AFO based on 
gastrocnemius length and stiffness improved gait mechanics for half of children compared to 
their conventionally-prescribed AFOs.  
Although the studies examined different aspects of AFO prescription, they reiterate key 
considerations from multiple perspectives. This thesis highlights three broad themes for 
exploration and growth – both through orthotic research and in clinical practice: 1) prioritizing 
objective evaluation at all ICF levels, especially participation, at initial prescription and follow-
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up; 2) collaboration and communication during goal setting, prescription decisions, and follow-
up; and 3) individualizing prescriptions (based on biomechanical rationale) through the 
development and use of evidence-based guidelines and algorithms to optimize outcomes. These 
themes form an inter-connected foundation for continued progress toward evidence-based AFO 
prescription and better mobility outcomes for children with CP.  
All three studies demonstrated the value of objective evaluation, which is essential to 
identify and quantify the characteristics of the child that are relevant to designing the initial 
prescription. Subsequently, follow-up evaluation allows clinicians to optimize the prescription. 
Although PTs do recognize the importance of follow-up evaluation, it may not always happen in 
practice (Chapter 3); furthermore, only a minority of adjustments appear to focus on 
biomechanical optimization of the AFO-FC (Chapter 4). Therefore, emphasizing objective 
follow-up assessment to tune the AFO-FC and optimize its alignment for activity may represent 
an opportunity to improve orthotic outcomes.  
Collaboration, resources, and environmental factors must also be considered. In the 
absence of collaboration, it becomes challenging to implement a clinical algorithm or incorporate 
evaluation findings into the prescription. For example, to individualize the AA-AFO in practice, 
consensus must be reached amongst the team members (including family) regarding mobility 
goals and the orthotic plan prior to fabrication. Resources and environmental factors must also 
support individualized prescription. For example, if the effectiveness of a clinical algorithm is 
dependent on footwear, yet appropriate shoes and modifications may be difficult or costly to 
obtain, (as is presently the case in Canada), then optimal results are less likely to be achieved. 
Although clinicians endeavor to individualize AFO prescriptions (Chapters 3 and 4), 
current practices rely on trial and error, habit, and inconsistent use of objective evaluation 
measures, primarily at the impairment level. This presents both challenges and opportunities for 
improvement. Chapter 5 illustrates potential benefits of individualizing the AA-AFO using a 
clinical algorithm. Indeed, algorithms appear to be a feasible and effective means of guiding 
simple orthotic decision-making in practice. However, further research is necessary to 
understand the factors that affect children’s responses to individual biomechanical aspects of the 
AFO prescription. It is likely that orthotic outcomes will improve as our understanding of these 
factors develops.  
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One challenge for clinicians is to shift the focus of prescription away from impairments 
and toward outcomes that children and families find meaningful. Participation-level goals have 
been described as being most important for children and families (Anaby et al., 2017; Schiariti & 
Masse, 2015); therefore, child-and family-centred care should involve goal-setting and objective 
evaluation at all levels of the ICF framework. Within the greater context of pediatric 
physiotherapy, there appears to be a growing acknowledgement that justification for the 
traditional focus on impairment-based interventions has not been demonstrated. It is therefore 
important for orthotic research to include studies of the effects of AFOs on participation and 
activity level outcomes (Bjornson et al., 2016; Harlaar et al., 2010). 
This thesis sets the stage for future research that will advance orthotic practice and 
management of gait impairments for children with CP. To maximize opportunities for research 
evidence to inform practice, analyses should explore the responses and characteristics of 
individuals (as we did in Chapter 5) or attempt to identify the patterns and factors affecting 
individual responses within groups of heterogenous individuals. Individual analyses have the 
potential to explore variation in treatment responses between individuals and to identify factors 
predicting or affecting those responses. The limitations of analyses based on measures of central 
tendency for children with CP have been described (Bowers & Ross, 2009; Damiano, 2014); 
however, such analyses pervade orthotic research and evidence grading systems.  
It is necessary for conventional clinical reasoning practices to move away from 
inefficient approaches that are based primarily on trial-and-error and anecdotal evidence, toward 
more research-based algorithms, clinical practice guidelines, and prescription decisions 
supported by evidence-based biomechanical rationales. A shift away from impairment-level 
outcome measures toward a focus on activity and participation goals is similarly needed to result 
in more meaningful, effective orthotic care. This thesis enhances the current understanding of 
how AFOs are prescribed for children with CP in Canada and provides an example of how 
individualizing one aspect of the AFO prescription – the AA-AFO – can improve gait mechanics 
for children with CP. By placing this knowledge in the context of current research evidence, 
future directions emerge, and new opportunities can be realized. 
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Appendix B. STROBE flow diagram summarizing collection and screening of survey 
responses (Chapter 4). 
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*Number of potentially eligible participants is unknown. 
 
 
  
6 survey responses excluded that 
did not meet inclusion criteria (i.e., 
respondent had not been involved 
in AFO prescription for a child with 
CP in the past 2 months) 
 
Survey link sent to physical 
therapists in Canada who 
work with children*  
66 survey responses received   
60 completed survey responses 
included in analysis   
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Project title: Understanding how physical therapists make decisions about ankle-foot 
orthoses (AFOs) 
Researcher: Kyra Kane, BScPT, MSc, PhD candidate, Health Sciences Program, University of 
Saskatchewan, kyra.kane@usask.ca 
  
Supervisors: 
- Kristin Musselman, PT, PhD, University Health Network and University of Toronto, 
kristin.musselman@uhn.ca 
- Joel Lanovaz, PhD, College of Kinesiology, University of Saskatchewan, (306) 9661073, 
Joel.lanovaz@usask.ca 
  
Purpose and Objectives of the Research: 
- We would like to find out how physical therapists (PTs) use evaluation measures to make 
decisions about AFOs for children with cerebral palsy (CP). 
- The information you provide will help support the development of recommendations to improve 
evaluation in AFO prescription. 
Procedures: 
- Physical therapists who are licensed in Canada and who have been involved with AFO 
prescription for a child with CP at least once in the past two months are invited to complete an 
online survey. The survey will take about 30 minutes to complete. 
- Responses from all surveys will be combined and summarized using descriptive statistics. 
- Please feel free to ask any questions regarding the procedures and goals of the study or your 
role. 
Potential Risks: 
- There are no known or anticipated risks to you by participating in this research. 
Potential Benefits: 
- There are no direct benefits to you for participating in this research. 
- The results from this research will inform rehabilitation professions about physical therapy 
assessment and decision-making for AFO prescription, and will provide initial clinical practice 
guidelines for AFO prescription. 
Compensation: 
- At the end of the survey, you will have the option to enter your email address into a draw for one 
of four $50 Amazon.ca gift cards. 
Confidentiality: 
- Survey responses are collected anonymously. 
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- If you enter your email address for the draw, your email address will be stored separately from the 
survey responses on a password-protected computer. The electronic file containing the email 
addresses will be deleted once the gift card draw has occurred. 
- This survey is hosted by SurveyMonkey, a USA owned company and subject to US laws. As such 
the privacy of the information you provide may be subject to the laws of that jurisdiction. By 
participating in this survey you acknowledge and agree that your answers/information will be 
stored in the USA and therefore may or may not receive the same level of privacy protection 
afforded by Canadian law. 
Right to Withdraw: 
- Your participation is voluntary. You may withdraw from the research project for any reason, at 
anytime without explanation or penalty. 
- Should you wish to withdraw, you can close the online survey in your web browser. 
Follow up: 
- To obtain results from the study, please contact Kyra Kane at kyra.kane@usask.ca. 
Questions or Concerns: 
- Contact the lead researcher (Kristin Musselman) using the information at the top of this page. 
This research project was reviewed and approved on ethical grounds through a harmonized 
review process by the University of Saskatchewan and Regina Qu’Appelle Health Region 
Research Ethics Boards. Any questions regarding your rights as a participant may be addressed 
to that committee through the U of S Research Ethics Office at ethics.office@usask.ca or (306) 
966-2975. 
Out of town participants may call toll-free at 1-888-966-2975. 
Consent: 
By completing and submitting the questionnaire, YOUR FREE AND INFORMED CONSENT IS 
IMPLIED and indicates that you understand the above conditions of participation in this study. 
 
Demographics 
Please tell us a bit about yourself. 
1. In the past 2 months, how often have you been involved in AFO prescription for a child with 
CP, or made decisions about the AFOs of a child with CP? (This may include checking or re-
assessing a child's AFOs as part of a treatment session, or contributing to decisions about new 
AFOs.) 
 I have not seen a child with CP who wears AFOs in the past 2 months. 
 Monthly (I see about 1-3 children per month with AFOs and CP) 
 Weekly (I see 1-4 children per week with AFOs and CP) 
 Daily (I see one child or more per day with AFOs and CP) 
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Demographics 
2. In which province do you work? 
 
3. How many years have you worked as a physiotherapist? 
 
4. How many years have you worked in paediatrics? 
 
5. Please describe your main work setting (Check all that apply.) 
Publicly-funded facility (hospital, rehabilitation centre) 
Privately-funded clinic 
Rural 
Urban 
 
6. Where are the orthotists that you work with located? (Check all that apply, if you frequently 
work with more than one orthotist.) 
 
7. How confident are you in your ability to recommend the correct AFO type (solid, hinged, etc.) 
and characteristics (stiffness, trimlines, ankle angle, etc.) for children with CP? 
 
On-site  
<1 km away  
>1 km away 
Other (please specify) 
Not confident at all Extremely confident 
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Section 1: Recommendations about AFO prescription 
The next questions relate to the following scenario:  
An 8-year-old ambulatory child with CP comes to you for an assessment. AFOs have been 
suggested for the child. The physician wants your recommendation about the AFO type (solid, 
hinged, etc.) and characteristics (stiffness, trimlines, ankle angle, etc.) before writing the 
prescription. 
 
8. Please select the items that you think would likely be most helpful in making this decision. 
 
 
 
9. You identified that you would normally consider the following information when deciding what 
type of AFO to recommend for a child with CP.  
How do you measure each item? If you use any specific tools, please list them (e.g., 
videorecording, goniometer, names of standardized outcome measures or clinical tests). 
 
Gait pattern (e.g., general gait appearance, crouch, scissoring etc.) 
Spatio-temporal variables (step length, velocity, etc.) 
Gross motor skills 
Bony alignment of foot and leg 
Range of motion - ankle, knee, hip 
Muscle strength  
Muscle tone (general resistance to passive movement or another measure of tone)  
R1 measurement for plantarflexor muscles  
Selective voluntary control of lower extremity 
Goals 
Shank to vertical angle and shank kinematics during gait 
Pain 
Leg length 
Parent/child preference about the type of AFO  
Participation in school/social/recreational activities 
Other (please specify or add a comment to elaborate on your answers above) 
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Muscle tone (general 
resistance 
to passive 
 
 
appearance: crouch, 
 scissoring etc.) 
Spatio-temporal variables 
) step length, velocity, etc. ( 
Gross motor skills 
Bony alignment of foot and 
leg 
Range of motion - ankle, 
knee, hip 
Ankle range of motion - 
dorsiflexion with knee 
extended 
Knee range of motion 
Hamstring length 
Muscle strength  
movement or another 
measure of tone)  
R1 measurement for 
plantarflexor muscles  
Selective voluntary control 
of lower extremity 
Goals 
Shank to vertical angle 
and shank kinematics 
during gait 
Pain 
Leg length 
Parent/child preference 
about the type of AFO  
Participation in 
school/social/recreational 
activities 
Gait pattern (e.g., general 
 
 
 
 a 
gait appearance, crouch, 
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Other (please specify or add a comment to elaborate on your answers above)
  
10. Of the information that you consider when recommending an AFO for a child, which ones 
usually influence your decision the most? 
Please list the three most important things that you assess, in order of their importance. 
 
11. How do you evaluate the child's gait, to make a decision about the type of AFO you are 
recommending?  
Always or 
 Rarely (<25% of Most of the time almost 
always 
 
12. You have finished assessing this ambulatory child for a new AFO.  
Most important information 
2 nd most important 
3 rd most important 
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Please describe the most important examination findings that would lead you to suggest each of 
the following AFO types. (If you do not use or are not familiar with the type of AFO, please 
indicate this): 
 
 
13. How do you decide whether a hinged AFO or a solid AFO is more appropriate for a child? If 
there are certain assessment findings that help you to decide between these 2 types of AFO, 
please describe them as specifically as you can. 
 
Section 2: Casting positions for the foot and ankle 
A doctor prescribes a new AFO for a child on your caseload, and a casting appointment 
is scheduled with an orthotist.  
The following questions relate to the recommendations you make about the position of 
the child's foot and ankle in a new AFO. 
14. For the children you see, how often do you provide recommendations to the orthotist about 
the position of the foot and ankle in the cast? 
 
Solid AFO 
Hinged AFO 
Ground reaction AFO 
Posterior leaf spring, or 
other semi-rigid AFO 
ESR (energy storage and 
return) AFO 
Carbon fiber AFO 
Never 
Rarely (<25% of the children I see) 
Sometimes (25-50% of the children I see) 
Usually (75-95% of the children I see) 
Always or almost always (95-100% of the children I see) 
Other (please comment) 
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15. For the children you see, how often are AFOs fabricated with the ankle positioned at a 
plantarflexed angle? 
 
16. What examination findings would cause you to recommend positioning the ankle at a 
plantarflexed angle in an AFO? 
 
17. How harmful or beneficial do you believe it is to position an ankle in plantarflexion in an AFO? 
 
18. Why do you think it may be harmful or beneficial to position an ankle in plantarflexion? 
 
Section 3: Follow-up evaluation for a new AFO 
The next questions are about PT follow-up evaluation for a child who has received a new 
AFO.  
9. An 8-year-old ambulatory child with CP comes in to see you after getting a new AFO.  
Please select the items you would likely assess, to evaluate the effects of the new AFO. 
Never 
Rarely (<25% of children) 
Sometimes (25-50% of children) 
Usually (75-95% of children) 
Always or almost always (95-100% of children) 
Other (please comment)  
Extremely harmful; not helpful 
under any circumstances Neither harmful nor beneficial 
Extremely beneficial in the 
right circumstances 
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20. You reported that you would normally consider the following information in your decision.  
How would you measure each item during your reassessment? If you use any specific tools, 
please list them (e.g., videorecording, goniometer, names of standardized outcome measures or 
clinical tests). 
Gait pattern (e.g., general gait appearance, crouch, scissoring etc.) 
Spatio-temporal variables (step length, velocity, etc.) 
Gross motor skills 
Bony alignment of foot and leg 
Range of motion - Ankle, knee, hip 
Muscle strength  
 Muscle tone (general resistance to passive movement or other measure of tone)  
R1 measurement for plantarflexor muscles ("first catch") 
Selective voluntary control of the lower extremity 
Goals 
Shank to vertical angle and shank kinematics during gait 
Pain 
Leg length 
Ask parent/child if they are happy with the AFO 
Participation in school/social/recreational activities 
Other (please specify) 
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 Muscle tone (general 
resistance to passive 
 
 
21. Of the information that you consider when re-assessing a child's AFO, which ones are usually 
the most helpful or informative?  
Please list the three most important things that you assess in order to evaluate the effect of an 
AFO, in order of their importance. 
Gait pattern (e.g., general 
appearance, crouch, 
scissoring etc.) 
Spatio-temporal variables 
( step length, velocity, etc. ) 
Gross motor skills 
Bony alignment of foot and 
leg 
Range of motion - Ankle, 
knee, hip 
Muscle strength  
movement or other 
measure of tone)  
R1 measurement for 
plantarflexor muscles 
) "first catch" ( 
Selective voluntary control 
of the lower extremity 
Goals 
Shank to vertical angle 
and shank kinematics 
during gait 
Pain 
Leg length 
Ask parent/child if they are 
happy with the AFO 
Participation in 
school/social/recreational 
activities 
Other (please specify) 
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22. Of the children you see with AFOs, approximately how many do you re-evaluate once they 
have a new AFO, to check how well the AFO is working for the child? 
 
23. How important do you think it is to complete a PT evaluation after a child gets a new AFO? 
 
Section 4: AFO-footwear combination adjustments and tuning 
The following questions are about adjustments to the AFO and footwear that you 
might make after a child receives a new AFO. 
24. When a child gets a new AFO, have you ever made or recommended adjustments (e.g., to the 
orthotist) to optimize how the child walks in it? 
 Yes 
 No 
 
25. Please describe some examples of adjustments that you usually make or recommend for the 
AFO and/or footwear, in order to improve the way the child walks. 
 
26. How often (i.e., for what percentage of children who get AFOs) do you make or recommend 
adjustments or modifications to the AFO or footwear? 
Most important information 
2 nd most important 
3 rd most important 
None  1-25 % of them 26-50 % of them 51-75 % of them 76-100 % of them 
Other (please specify) 
Not at all important 
or beneficial Somewhat beneficial 
Extremely important and 
beneficial 
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27. How do you evaluate the AFO with the footwear to make this decision? 
 Always or 
 Rarely (<25% of                             Most of the time     almost always 
 
 
Final comments 
28. Is there anything you would like to suggest, in order to improve assessment and 
prescription/recommendation of AFOs? 
 
Thank you for completing this survey! 
If you would like to enter the draw for one of four $50 Amazon gift cards, please click on the link below. Here, you will be 
able to enter your email address for the draw. This allows the researchers to keep your email address separate from your 
survey answers.   
https://www.surveymonkey.com/r/6F9BW72  
Rarely (1-25% of children) Sometimes (26-50% of children) Often (51-75% of chidren) 
Almost always (>75% of 
children) 
Other (please specify or add a comment) 
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WNL: Within normal limits; FPA: Foot progression angle; MTA: Metatarsus adductus; LLD: Leg length discrepancy; PROM: passive range of 
motion (measured by goniometer) 
*Evaluation measures performed according to Cusick (2006, 2009)& Owen, (2016). WNL on the unaffected side for children with unilateral 
CP. 
aMild= foot axis through 3rd toe; moderate= foot axis between 3rd and 4th toes; severe= foot axis between 4th and 5th toes (Staheli, 2006) 
bPositive values denote hyperextension and negative values denote contracture; cPositive values denote external torsion and negative values 
denote internal torsion   
Table D.1. Physical assessment findings for participants with CP * 
Child 
(Limb)  
Foot posture Forefoot 
posturea 
Foot 
flexibility 
Knee  
Extension 
PROMb 
TFAc Femoral 
anteversion  
Duncan Ely  
Test 
Thomas 
Test 
LLD 
1(R) Pronation, midfoot 
break 
WNL Flexible to 
neutral 
-10˚ -3˚ Yes WNL -5˚ 1cm short 
1(L) Neutral Equinus Flexible to 
neutral 
0˚ WNL WNL WNL WNL - 
2(R) Inversion/ supination, 
midfoot break 
Moderate MTA Flexible 0˚ 0˚ WNL WNL WNL 1.5cm short 
3(R) Calcaneovalgus Equinus Fixed 0˚ WNL WNL WNL -5⁰ 2cm short 
3(L) WNL WNL Flexible to 
neutral 
0⁰ WNL WNL WNL -5⁰ - 
4(R) Calcaneovarus Severe MTA Fixed 10˚ 0˚ Yes Positive -5˚ - 
4(L) Calcaneovarus Severe MTA Fixed 0˚ 5˚ WNL WNL WNL 0.5cm short 
5(L) Equinus, inversion, 
hindfoot varus 
WNL Flexible 0˚ 0˚ Yes WNL WNL 1cm short 
6(R) WNL Equinus Flexible 0˚ 2˚ WNL mild positive -5˚ 1cm short 
7(R) Cavus with forefoot 
equinus 
Hallux valgus; 
Mild MTA 
Flexible 0˚ 15˚ WNL WNL WNL 1.5cm short 
8(R) Supination Severe MTA Fixed MTA 0˚ -5˚ WNL positive WNL 0.5cm short 
9(R) Cavus Moderate MTA Flexible 10˚ 0˚ WNL  WNL -10˚ 1cm short 
9(L) Internal Moderate MTA Flexible -5˚ 0˚ Yes  WNL WNL - 
10(R) Midfoot break; 
hindfoot varus 
Moderate MTA Flexible to 
neutral 
0˚ 5˚ WNL WNL WNL - 
10(L) Midfoot break; 
supination 
Moderate MTA  Flexible to 
neutral 
0˚ 5˚ WNL WNL -15˚ 0.5cm short 
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WNL: Within normal limits; R: Right; L: Left 
*Measured in degrees using a universal goniometer according to Boyd & Graham (1999) 
  
Table D.2. Modified Tardieu Scale scores for participants with CP: R1 and R2 angles*  
Child 
(Limb) 
Hip 
Extension 
Hip 
Abduction 
Hip 
External 
Rotation 
Hip Internal 
Rotation 
Knee 
Extension 
Knee 
Flexion 
Ankle PF at 
90 
Ankle PF at 
0 
R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 
1 (R) WNL 45⁰ 30⁰ 30⁰ WNL 45⁰ 0⁰ 45⁰ WNL WNL -90⁰ -50⁰ 0⁰ 0⁰ -30⁰ -20⁰ 
1 (L) WNL 45⁰ 30⁰ 30⁰ WNL 35⁰ 0⁰ 50⁰ WNL WNL -85⁰ -50⁰ -5⁰ 0⁰ -30⁰ -15⁰ 
2 (R) 50⁰ WNL 25⁰ 65⁰ WNL 65⁰ WNL 55⁰ WNL WNL -90⁰ -45⁰ 0⁰ 0⁰ -16⁰ -10⁰ 
2(L) \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ 
3 (R) WNL WNL WNL WNL WNL 35⁰ WNL WNL WNL WNL -50⁰ -26⁰ -10⁰ 5⁰ -25⁰ 0⁰ 
3 (L) WNL WNL WNL WNL WNL 45⁰ WNL WNL WNL WNL WNL -32⁰ 5⁰ 10⁰ -10⁰ 0⁰ 
4 (R) WNL WNL WNL 30⁰ WNL 55⁰ WNL 70⁰ WNL WNL -80⁰ -40⁰ WNL 5⁰ -20⁰ -4⁰ 
4 (L) WNL WNL WNL 30⁰ 10⁰ 40⁰ WNL 70⁰ WNL WNL -60⁰ -35⁰ WNL 5⁰ -20⁰ -7⁰ 
5(R) \ \ \ \ \ 70⁰ \ 70⁰ \ \ \ \ \ \ \ \ 
5(L) WNL WNL WNL WNL WNL 75⁰ WNL 60⁰ WNL WNL -50⁰ -35⁰ WNL WNL -40⁰ 5⁰ 
6(R) WNL WNL WNL WNL WNL 60⁰ WNL 40⁰ WNL WNL -60⁰ -45⁰ WNL 7⁰ -15⁰ -4⁰ 
6(L) \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ 
7(R) WNL WNL WNL WNL WNL 70⁰ WNL 70⁰ WNL WNL -55⁰ -45⁰ WNL 6⁰ -18⁰ 0⁰ 
7(L) \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ 
8(R) WNL WNL WNL WNL WNL WNL WNL WNL WNL WNL -80⁰ -40⁰ 15⁰ 25⁰ -15⁰ 2⁰ 
8(L) \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ 
9(R) WNL WNL WNL WNL WNL WNL WNL WNL WNL WNL -50⁰ 0⁰ 0⁰ 15⁰ -15⁰ 8⁰ 
9(L) WNL WNL WNL WNL WNL WNL WNL WNL WNL WNL -40⁰ 0⁰ 0⁰ 18⁰ 0⁰ 10⁰ 
10(R) WNL WNL WNL WNL WNL 60⁰ WNL 45⁰ WNL WNL -50⁰ -30⁰ WNL 10⁰ -15⁰ 3⁰ 
10(L) WNL WNL WNL WNL WNL 50⁰ WNL 50⁰ WNL WNL -60⁰ -40⁰ WNL 10⁰ -30⁰ 0⁰ 
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Table D.3. Subjective comments about the iAA-AFOs, gait observations, and response to iAA-AFOs based on visual analysis of data 
Child Subjective comments about the 
iAA-AFOs  
Gait observations  
 
Change with iAA-AFO based 
on visual analysis 
Net 
Response 
1 Felt more comfortable walking in 
Usual AFOs but after some 
practice, she said she felt like she 
stood taller in the iAA-AFOs. 
Would like to wear iAA-AFOs for 
graduation photos or basketball 
but Usual AFOs for other 
activities. 
- IC with forefoot on L  
- pronates R>L  
- intoes R (~30⁰ FPA)  
- R: crouch with ankle dorsiflexion 
- L: excess KF at IC  
- Bilateral KHE in stance phase 
- Weightbears more on L than R 
- Short step length 
R: More peak KE (better) 
 
Positive 
L: Less KF in IC/LR (Better), 
followed by more KHE 
(Worse) 
Negative 
2 Skin tolerance was best with iAA-
AFO: reduced pressure and 
friction over the navicular.  
- IC with flatfoot 
- mild equinus 
- Pronation 
- Neutral FPA 
Better knee pattern (KF in LR 
and TSt KE)  
Positive 
3 Experienced pain in Usual AFOs; 
chose the iAA-AFOs to wear 
afterward because they felt more 
comfortable. 
- IC with flatfoot on R and bilateral KF  
- pronates bilaterally 
- foot drop and foot slap on R 
- Minimal impairment on L 
- neutral FPA 
R: Increase in KHE (Worse) Negative 
L: Minimal difference 
(GVS_FFA worse)  
Negative 
4 No preference. - IC with forefoot or flatfoot  
- internal FPA on R 
- early stance KF on R 
- bilateral KHE 
R: Less KF at IC/LR (Better); 
more KHE in stance (Worse); 
IC with heel and better FFA & 
SVA 
Positive 
L: increase KF in LR (Worse); 
slightly less KHE in stance 
(Better) 
Negative 
5 Chose to wear iAA-AFO after 
testing 
- Winter-Gage-Hicks type IV gait 
- IC with forefoot 
- Rarely achieves heel contact in stance on L 
- KE thrust in late stance 
- FPA: ~45⁰ internal  
~10⁰ less KHE, but difference 
was not significant; consistent 
gains in KE moment and SVA, 
but not significant; better FFA 
at IC 
Negative 
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6 Chose to wear iAA-AFO after 
testing 
- IC with flatfoot 
- Decreased stance time on R  
Knee moment looks better but 
not significant 
Equivocal 
7 Did not like the iAA-AFO; 
prefers the carbon fiber AFO as it 
is easier to put on 
- IC with flatfoot 
- Pronates 
- excess KF 
- FPA: ~25⁰ external  
More KE (Better) Positive 
8 Got a new AFO with AA-AFO in 
PF and tolerates it well. 
- IC with forefoot, with knee and hip flexed, 
then KE  
- FPA: ~40⁰ internal; internally rotates at hip  
A bit less KHE but not 
significant 
Equivocal 
9 Participant’s mother thought the 
shoe raise improved her gait 
pattern during testing, so she got 
one afterward; participant was 
nervous about walking in the 
iAA-AFO and would only walk 
with her hand held during the test 
- IC with forefoot 
- IC with KHE on R 
- Excess KF on L  
- Runs with marked equinus and hindfoot 
varus and KHE 
- FPA: bilateral intoing (mild)  
R: More KHE (Worse) Equivocal 
L: Decreased KF (Better) Positive 
10 Chose to wear iAA-AFO after 
testing; feels her gait pattern 
and balance are much better in 
iAA-AFO (reports that falls 
have decreased 75%) 
Weightbears on R>L;  
IC with forefoot contact and KF 
Sometimes supinates, sometimes pronates 
KHE in stance 
FPA ~40⁰ internal on R and 20⁰ internal on 
L 
R: Less KHE (Better) Positive 
L: Less KHE (Better) Positive 
R: Right; L: Left; IC: initial contact; LR: loading response; FPA: Foot progression angle; KE: knee extension; KF: knee flexion; KHE: 
knee hyperextension 
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Table D.4. Responses to the iAA-AFO by limb and child for variables included in responder analysis: A. Knee variables; B. Hip 
variables; C. Segment, ground reaction force, and spatio-temporal variables. 
A. 
Child Limb KneeIC KneeFlex KneeExt 
KneeMom_ 
LR 
KneeMom_ 
TMSt 
KneeMom_ 
TS 
GVS_ 
Knee 
GVS_ 
KneeMom 
1 
 
R 0 0 1 WNL 0 0 0 0 
L 1 1 2 2 0 0 2 2 
2 R 0 0 WNL 0 0 0 1 1 
3 
 
R 0 2 0 2 1 0 0 0 
L WNL WNL WNL WNL 0 0 WNL WNL 
4 
 
R 1 1 0 WNL 0 0 0 WNL 
L 0 2 1 0 0 0 2 2 
5 L 0 0 0 0 0 0 0 WNL 
6 R 0 WNL WNL 1 1 0 WNL 0 
7 R 1 0 1 1 2 0 1 0 
8 R 0 0 0 0 0 0 0 0 
9 
 
R 0 0 2 NT NT NT 0 NT 
L 0 1 1 NT NT NT 1 NT 
10 
 
R 0 0 1 0 1 1 1 1 
L WNL 1 1 1 1 0 1 1 
Positive Response 20% 27% 40% 23% 31% 8% 33% 23% 
Negative Response 0% 13% 13% 15% 8% 0% 13% 15% 
No Change/ WNL 80% 60% 47% 62% 62% 92% 53% 62% 
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B. 
Child Limb HipFlex HipExt HipExtMom HipFlexMom GVS_Hip GVS_HipMom 
1 
 
R 0 0 0 0 0 0 
L 0 0 0 2 WNL 0 
2 R WNL 0 0 0 0 0 
3 
 
R WNL WNL WNL 0 WNL 0 
L 0 WNL 0 0 WNL 0 
4 
 
R 1 WNL 0 WNL 0 0 
L 0 0 WNL 0 0 0 
5 L 0 0 2 0 0 WNL 
6 R WNL 1 WNL 0 WNL 2 
7 R 1 2 1 0 0 0 
8 R WNL 1 WNL 0 0 0 
9 
 
R WNL 0 NT NT 0 NT 
L 1 0 NT NT 0 NT 
10 
 
R 0 2 1 WNL 2 1 
L WNL 2 0 0 2 0 
Positive Response 20% 13% 15% 0% 0% 8% 
Negative Response 0% 20% 8% 8% 13% 8% 
No Change/WNL 80% 67% 77% 92% 87% 85% 
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C. 
Child Limb 
SVA_ 
IC 
SVA_ 
TMSt 
GVS_ 
SVA 
FFA_ 
IC 
FFA_ 
TMSt 
GVS_ 
FFA 
GVS_ 
VF 
Stride 
Velocity 
Stride 
Length 
Stride 
Time 
Stance 
Percent 
1 
 
R 0 0 0 0 0 0 0 0 0 0 0 
L 0 WNL 0 0 0 2 2 2 2 0 0 
2 R 0 0 0 WNL WNL 1 0 0 0 0 0 
3 
 
R 0 2 2 2 2 2 0 WNL 0 0 0 
L 0 WNL 0 0 0 2 WNL WNL 0 0 WNL 
4 
 
R 1 1 0 0 WNL 0 2 0 0 0 0 
L 0 0 0 1 1 2 2 0 0 0 WNL 
5 L 0 0 0 WNL WNL WNL 0 0 WNL 0 WNL 
6 R 0 0 0 0 0 0 0 WNL 0 0 0 
7 R 1 1 1 1 1 0 0 0 1 0 0 
8 R 0 0 0 WNL WNL 0 0 0 WNL 0 0 
9 
 
R 0 0 0 0 0 0 X 0 0 WNL 0 
L 0 0 0 0 0 0 X 0 0 WNL 0 
10 
 
R 0 0 0 0 0 0 1 0 0 0 0 
L 0 0 2 1 2 2 0 0 0 0 0 
Positive Response 13% 13% 7% 20% 13% 7% 8% 0% 7% 0% 0% 
Negative Response 0% 7% 13% 7% 13% 33% 23% 7% 7% 0% 0% 
No Change/ WNL 87% 80% 80% 73% 73% 60% 69% 93% 87% 100% 100% 
Response types:  
0 = No difference between conditions (i.e. CI overlap) 
1 = iAA-AFO closer to the TD value than Usual (i.e. positive response) 
2 = iAA-AFO farther from the TD value than Usual (i.e. -negative response) 
WNL= Within normal limits (Both conditions within 1 SD of TD value) 
NT= Not tested 
R: Right; L: Left 
